JP2023006915A - Translucent or transparent topical skin preparation - Google Patents
Translucent or transparent topical skin preparation Download PDFInfo
- Publication number
- JP2023006915A JP2023006915A JP2021109783A JP2021109783A JP2023006915A JP 2023006915 A JP2023006915 A JP 2023006915A JP 2021109783 A JP2021109783 A JP 2021109783A JP 2021109783 A JP2021109783 A JP 2021109783A JP 2023006915 A JP2023006915 A JP 2023006915A
- Authority
- JP
- Japan
- Prior art keywords
- oil
- ppg
- hydrogenated castor
- skin
- castor oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 55
- 230000000699 topical effect Effects 0.000 title abstract 3
- 239000007787 solid Substances 0.000 claims abstract description 45
- 239000007788 liquid Substances 0.000 claims abstract description 22
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 22
- 229930195733 hydrocarbon Natural products 0.000 claims abstract description 17
- 150000002430 hydrocarbons Chemical class 0.000 claims abstract description 16
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 15
- 150000005846 sugar alcohols Polymers 0.000 claims abstract description 15
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 14
- 239000003921 oil Substances 0.000 claims description 59
- 239000004359 castor oil Substances 0.000 claims description 41
- 235000019438 castor oil Nutrition 0.000 claims description 41
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims description 41
- -1 polyoxyethylene Polymers 0.000 claims description 37
- 229920003171 Poly (ethylene oxide) Polymers 0.000 claims description 16
- 239000004215 Carbon black (E152) Substances 0.000 claims description 15
- GTABBGRXERZUAH-UHFFFAOYSA-N hexadecan-1-ol;2-methyloxirane;oxirane Chemical compound C1CO1.CC1CO1.CCCCCCCCCCCCCCCCO GTABBGRXERZUAH-UHFFFAOYSA-N 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 12
- NLMKTBGFQGKQEV-UHFFFAOYSA-N 2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-[2-(2-hexadecoxyethoxy)ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethanol Chemical compound CCCCCCCCCCCCCCCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO NLMKTBGFQGKQEV-UHFFFAOYSA-N 0.000 claims description 6
- DTPCFIHYWYONMD-UHFFFAOYSA-N decaethylene glycol Chemical compound OCCOCCOCCOCCOCCOCCOCCOCCOCCOCCO DTPCFIHYWYONMD-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims 1
- 235000019198 oils Nutrition 0.000 description 55
- 210000003491 skin Anatomy 0.000 description 54
- 239000000284 extract Substances 0.000 description 30
- 235000014113 dietary fatty acids Nutrition 0.000 description 29
- 239000000194 fatty acid Substances 0.000 description 29
- 229930195729 fatty acid Natural products 0.000 description 29
- 230000000694 effects Effects 0.000 description 19
- 239000004166 Lanolin Substances 0.000 description 17
- 235000019388 lanolin Nutrition 0.000 description 17
- 229940039717 lanolin Drugs 0.000 description 17
- 150000004665 fatty acids Chemical class 0.000 description 14
- 239000003795 chemical substances by application Substances 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 9
- 239000000539 dimer Substances 0.000 description 8
- 238000004519 manufacturing process Methods 0.000 description 8
- 239000012071 phase Substances 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- NOPFSRXAKWQILS-UHFFFAOYSA-N docosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCCCO NOPFSRXAKWQILS-UHFFFAOYSA-N 0.000 description 6
- 238000011156 evaluation Methods 0.000 description 6
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 5
- 239000002253 acid Substances 0.000 description 5
- 235000019864 coconut oil Nutrition 0.000 description 5
- 239000003240 coconut oil Substances 0.000 description 5
- BTFJIXJJCSYFAL-UHFFFAOYSA-N icosan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCCCO BTFJIXJJCSYFAL-UHFFFAOYSA-N 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- 230000003020 moisturizing effect Effects 0.000 description 5
- 239000004094 surface-active agent Substances 0.000 description 5
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- 150000001298 alcohols Chemical class 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 238000009472 formulation Methods 0.000 description 4
- 229940119170 jojoba wax Drugs 0.000 description 4
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 4
- 239000010466 nut oil Substances 0.000 description 4
- 229940032094 squalane Drugs 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 210000000434 stratum corneum Anatomy 0.000 description 4
- AVBJHQDHVYGQLS-UHFFFAOYSA-N 2-(dodecanoylamino)pentanedioic acid Chemical compound CCCCCCCCCCCC(=O)NC(C(O)=O)CCC(O)=O AVBJHQDHVYGQLS-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
- 235000018330 Macadamia integrifolia Nutrition 0.000 description 3
- 235000003800 Macadamia tetraphylla Nutrition 0.000 description 3
- 240000000912 Macadamia tetraphylla Species 0.000 description 3
- 229930182558 Sterol Natural products 0.000 description 3
- 239000008346 aqueous phase Substances 0.000 description 3
- 235000013871 bee wax Nutrition 0.000 description 3
- 239000012166 beeswax Substances 0.000 description 3
- 125000002511 behenyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 3
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 239000002537 cosmetic Substances 0.000 description 3
- 229960000735 docosanol Drugs 0.000 description 3
- 239000008213 purified water Substances 0.000 description 3
- 150000003432 sterols Chemical class 0.000 description 3
- 235000003702 sterols Nutrition 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- DSEKYWAQQVUQTP-XEWMWGOFSA-N (2r,4r,4as,6as,6as,6br,8ar,12ar,14as,14bs)-2-hydroxy-4,4a,6a,6b,8a,11,11,14a-octamethyl-2,4,5,6,6a,7,8,9,10,12,12a,13,14,14b-tetradecahydro-1h-picen-3-one Chemical compound C([C@H]1[C@]2(C)CC[C@@]34C)C(C)(C)CC[C@]1(C)CC[C@]2(C)[C@H]4CC[C@@]1(C)[C@H]3C[C@@H](O)C(=O)[C@@H]1C DSEKYWAQQVUQTP-XEWMWGOFSA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 229940043375 1,5-pentanediol Drugs 0.000 description 2
- WAYINTBTZWQNSN-UHFFFAOYSA-N 11-methyldodecyl 3,5,5-trimethylhexanoate Chemical compound CC(C)CCCCCCCCCCOC(=O)CC(C)CC(C)(C)C WAYINTBTZWQNSN-UHFFFAOYSA-N 0.000 description 2
- ULQISTXYYBZJSJ-UHFFFAOYSA-N 12-hydroxyoctadecanoic acid Chemical compound CCCCCCC(O)CCCCCCCCCCC(O)=O ULQISTXYYBZJSJ-UHFFFAOYSA-N 0.000 description 2
- JNAYPSWVMNJOPQ-UHFFFAOYSA-N 2,3-bis(16-methylheptadecanoyloxy)propyl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCC(C)C)COC(=O)CCCCCCCCCCCCCCC(C)C JNAYPSWVMNJOPQ-UHFFFAOYSA-N 0.000 description 2
- LEEDMQGKBNGPDN-UHFFFAOYSA-N 2-methylnonadecane Chemical compound CCCCCCCCCCCCCCCCCC(C)C LEEDMQGKBNGPDN-UHFFFAOYSA-N 0.000 description 2
- SVTBMSDMJJWYQN-UHFFFAOYSA-N 2-methylpentane-2,4-diol Chemical compound CC(O)CC(C)(C)O SVTBMSDMJJWYQN-UHFFFAOYSA-N 0.000 description 2
- LEACJMVNYZDSKR-UHFFFAOYSA-N 2-octyldodecan-1-ol Chemical compound CCCCCCCCCCC(CO)CCCCCCCC LEACJMVNYZDSKR-UHFFFAOYSA-N 0.000 description 2
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 2
- FPVVYTCTZKCSOJ-UHFFFAOYSA-N Ethylene glycol distearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCOC(=O)CCCCCCCCCCCCCCCCC FPVVYTCTZKCSOJ-UHFFFAOYSA-N 0.000 description 2
- AEMRFAOFKBGASW-UHFFFAOYSA-N Glycolic acid Chemical compound OCC(O)=O AEMRFAOFKBGASW-UHFFFAOYSA-N 0.000 description 2
- 239000005639 Lauric acid Substances 0.000 description 2
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 2
- OFOBLEOULBTSOW-UHFFFAOYSA-N Malonic acid Chemical compound OC(=O)CC(O)=O OFOBLEOULBTSOW-UHFFFAOYSA-N 0.000 description 2
- AOMUHOFOVNGZAN-UHFFFAOYSA-N N,N-bis(2-hydroxyethyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)N(CCO)CCO AOMUHOFOVNGZAN-UHFFFAOYSA-N 0.000 description 2
- 240000007594 Oryza sativa Species 0.000 description 2
- 235000007164 Oryza sativa Nutrition 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 235000021302 avocado oil Nutrition 0.000 description 2
- 239000008163 avocado oil Substances 0.000 description 2
- OGBUMNBNEWYMNJ-UHFFFAOYSA-N batilol Chemical compound CCCCCCCCCCCCCCCCCCOCC(O)CO OGBUMNBNEWYMNJ-UHFFFAOYSA-N 0.000 description 2
- 229910052799 carbon Inorganic materials 0.000 description 2
- 229940082500 cetostearyl alcohol Drugs 0.000 description 2
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 2
- 229940105990 diglycerin Drugs 0.000 description 2
- GPLRAVKSCUXZTP-UHFFFAOYSA-N diglycerol Chemical compound OCC(O)COCC(O)CO GPLRAVKSCUXZTP-UHFFFAOYSA-N 0.000 description 2
- 150000002009 diols Chemical class 0.000 description 2
- UKMSUNONTOPOIO-UHFFFAOYSA-N docosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCCCC(O)=O UKMSUNONTOPOIO-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 230000008020 evaporation Effects 0.000 description 2
- 238000001704 evaporation Methods 0.000 description 2
- WSFSSNUMVMOOMR-UHFFFAOYSA-N formaldehyde Natural products O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 2
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 2
- 239000001685 glycyrrhizic acid Substances 0.000 description 2
- 229960004949 glycyrrhizic acid Drugs 0.000 description 2
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 2
- 235000019410 glycyrrhizin Nutrition 0.000 description 2
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 2
- SFFVATKALSIZGN-UHFFFAOYSA-N hexadecan-7-ol Chemical compound CCCCCCCCCC(O)CCCCCC SFFVATKALSIZGN-UHFFFAOYSA-N 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 description 2
- OQILCOQZDHPEAZ-UHFFFAOYSA-N octyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCC OQILCOQZDHPEAZ-UHFFFAOYSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 2
- WCVRQHFDJLLWFE-UHFFFAOYSA-N pentane-1,2-diol Chemical compound CCCC(O)CO WCVRQHFDJLLWFE-UHFFFAOYSA-N 0.000 description 2
- 229960005323 phenoxyethanol Drugs 0.000 description 2
- 150000003904 phospholipids Chemical class 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 235000009566 rice Nutrition 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000001953 sensory effect Effects 0.000 description 2
- GEHJYWRUCIMESM-UHFFFAOYSA-L sodium sulfite Chemical compound [Na+].[Na+].[O-]S([O-])=O GEHJYWRUCIMESM-UHFFFAOYSA-L 0.000 description 2
- 230000007928 solubilization Effects 0.000 description 2
- 238000005063 solubilization Methods 0.000 description 2
- 239000002904 solvent Substances 0.000 description 2
- 239000008347 soybean phospholipid Substances 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 239000010497 wheat germ oil Substances 0.000 description 2
- WTVHAMTYZJGJLJ-UHFFFAOYSA-N (+)-(4S,8R)-8-epi-beta-bisabolol Natural products CC(C)=CCCC(C)C1(O)CCC(C)=CC1 WTVHAMTYZJGJLJ-UHFFFAOYSA-N 0.000 description 1
- RGZSQWQPBWRIAQ-CABCVRRESA-N (-)-alpha-Bisabolol Chemical compound CC(C)=CCC[C@](C)(O)[C@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-CABCVRRESA-N 0.000 description 1
- INLFWQCRAJUDCR-IQVMEADQSA-N (1R,2S,4S,5'S,6R,7S,8R,9S,12S,13S)-5',7,9,13-tetramethylspiro[5-oxapentacyclo[10.8.0.02,9.04,8.013,18]icosane-6,2'-oxane] Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CCCCC4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@]11CC[C@H](C)CO1 INLFWQCRAJUDCR-IQVMEADQSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- BJDAUCLANVMIOB-UHFFFAOYSA-N (3-decanoyloxy-2,2-dimethylpropyl) decanoate Chemical compound CCCCCCCCCC(=O)OCC(C)(C)COC(=O)CCCCCCCCC BJDAUCLANVMIOB-UHFFFAOYSA-N 0.000 description 1
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- YYGNTYWPHWGJRM-UHFFFAOYSA-N (6E,10E,14E,18E)-2,6,10,15,19,23-hexamethyltetracosa-2,6,10,14,18,22-hexaene Chemical compound CC(C)=CCCC(C)=CCCC(C)=CCCC=C(C)CCC=C(C)CCC=C(C)C YYGNTYWPHWGJRM-UHFFFAOYSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- TZCPCKNHXULUIY-RGULYWFUSA-N 1,2-distearoyl-sn-glycero-3-phosphoserine Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC[C@H](COP(O)(=O)OC[C@H](N)C(O)=O)OC(=O)CCCCCCCCCCCCCCCCC TZCPCKNHXULUIY-RGULYWFUSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- OOWQBDFWEXAXPB-IBGZPJMESA-N 1-O-hexadecyl-sn-glycerol Chemical compound CCCCCCCCCCCCCCCCOC[C@@H](O)CO OOWQBDFWEXAXPB-IBGZPJMESA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- UCNQNZOSHKDAKL-UHFFFAOYSA-N 10-[5,6-dihexyl-2-[8-(16-methylheptadecanoyloxy)octyl]cyclohex-3-en-1-yl]dec-9-enyl 16-methylheptadecanoate Chemical compound CCCCCCC1C=CC(CCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C)C(C=CCCCCCCCCOC(=O)CCCCCCCCCCCCCCC(C)C)C1CCCCCC UCNQNZOSHKDAKL-UHFFFAOYSA-N 0.000 description 1
- 229940114072 12-hydroxystearic acid Drugs 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- ZONJATNKKGGVSU-UHFFFAOYSA-N 14-methylpentadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCC(O)=O ZONJATNKKGGVSU-UHFFFAOYSA-N 0.000 description 1
- VRACDWUCKIDHCO-UHFFFAOYSA-N 16-methylheptadecyl 10-[5,6-dihexyl-2-[8-(16-methylheptadecoxy)-8-oxooctyl]cyclohex-3-en-1-yl]dec-9-enoate Chemical compound CCCCCCC1C=CC(CCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C)C(C=CCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C)C1CCCCCC VRACDWUCKIDHCO-UHFFFAOYSA-N 0.000 description 1
- JSOVGYMVTPPEND-UHFFFAOYSA-N 16-methylheptadecyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCCCCCCCCCOC(=O)C(C)(C)C JSOVGYMVTPPEND-UHFFFAOYSA-N 0.000 description 1
- XFOQWQKDSMIPHT-UHFFFAOYSA-N 2,3-dichloro-6-(trifluoromethyl)pyridine Chemical compound FC(F)(F)C1=CC=C(Cl)C(Cl)=N1 XFOQWQKDSMIPHT-UHFFFAOYSA-N 0.000 description 1
- FLPJVCMIKUWSDR-UHFFFAOYSA-N 2-(4-formylphenoxy)acetamide Chemical compound NC(=O)COC1=CC=C(C=O)C=C1 FLPJVCMIKUWSDR-UHFFFAOYSA-N 0.000 description 1
- UMHYVXGZRGOICM-AUYXYSRISA-N 2-[(z)-octadec-9-enoyl]oxypropyl (z)-octadec-9-enoate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(C)OC(=O)CCCCCCC\C=C/CCCCCCCC UMHYVXGZRGOICM-AUYXYSRISA-N 0.000 description 1
- WMYINDVYGQKYMI-UHFFFAOYSA-N 2-[2,2-bis(hydroxymethyl)butoxymethyl]-2-ethylpropane-1,3-diol Chemical compound CCC(CO)(CO)COCC(CC)(CO)CO WMYINDVYGQKYMI-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-IVMDWMLBSA-N 2-amino-2-deoxy-D-glucopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O MSWZFWKMSRAUBD-IVMDWMLBSA-N 0.000 description 1
- 229940058020 2-amino-2-methyl-1-propanol Drugs 0.000 description 1
- CAYHVMBQBLYQMT-UHFFFAOYSA-N 2-decyltetradecan-1-ol Chemical compound CCCCCCCCCCCCC(CO)CCCCCCCCCC CAYHVMBQBLYQMT-UHFFFAOYSA-N 0.000 description 1
- VDHIEQOYPSVNIM-UHFFFAOYSA-N 2-hexyldecyl 2-ethylhexanoate Chemical compound CCCCCCCCC(CCCCCC)COC(=O)C(CC)CCCC VDHIEQOYPSVNIM-UHFFFAOYSA-N 0.000 description 1
- OGJDIJKJFYOENF-UHFFFAOYSA-N 2-hexyldecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCC)CCCCCCCC OGJDIJKJFYOENF-UHFFFAOYSA-N 0.000 description 1
- QNJOVLAFLJQFBF-UHFFFAOYSA-N 2-octyldodecyl 16-methylheptadecanoate Chemical compound CCCCCCCCCCC(CCCCCCCC)COC(=O)CCCCCCCCCCCCCCC(C)C QNJOVLAFLJQFBF-UHFFFAOYSA-N 0.000 description 1
- BGRXBNZMPMGLQI-UHFFFAOYSA-N 2-octyldodecyl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OCC(CCCCCCCC)CCCCCCCCCC BGRXBNZMPMGLQI-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- UIVPNOBLHXUKDX-UHFFFAOYSA-N 3,5,5-trimethylhexyl 3,5,5-trimethylhexanoate Chemical compound CC(C)(C)CC(C)CCOC(=O)CC(C)CC(C)(C)C UIVPNOBLHXUKDX-UHFFFAOYSA-N 0.000 description 1
- NCZPCONIKBICGS-UHFFFAOYSA-N 3-(2-ethylhexoxy)propane-1,2-diol Chemical compound CCCCC(CC)COCC(O)CO NCZPCONIKBICGS-UHFFFAOYSA-N 0.000 description 1
- XPFCZYUVICHKDS-UHFFFAOYSA-N 3-methylbutane-1,3-diol Chemical compound CC(C)(O)CCO XPFCZYUVICHKDS-UHFFFAOYSA-N 0.000 description 1
- GNKZMNRKLCTJAY-UHFFFAOYSA-N 4'-Methylacetophenone Chemical compound CC(=O)C1=CC=C(C)C=C1 GNKZMNRKLCTJAY-UHFFFAOYSA-N 0.000 description 1
- HBTAOSGHCXUEKI-UHFFFAOYSA-N 4-chloro-n,n-dimethyl-3-nitrobenzenesulfonamide Chemical compound CN(C)S(=O)(=O)C1=CC=C(Cl)C([N+]([O-])=O)=C1 HBTAOSGHCXUEKI-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- KGKQNDQDVZQTAG-UHFFFAOYSA-N 8-methylnonyl 2,2-dimethylpropanoate Chemical compound CC(C)CCCCCCCOC(=O)C(C)(C)C KGKQNDQDVZQTAG-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- 235000006667 Aleurites moluccana Nutrition 0.000 description 1
- 244000136475 Aleurites moluccana Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- JEBFVOLFMLUKLF-IFPLVEIFSA-N Astaxanthin Natural products CC(=C/C=C/C(=C/C=C/C1=C(C)C(=O)C(O)CC1(C)C)/C)C=CC=C(/C)C=CC=C(/C)C=CC2=C(C)C(=O)C(O)CC2(C)C JEBFVOLFMLUKLF-IFPLVEIFSA-N 0.000 description 1
- 235000021357 Behenic acid Nutrition 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- 239000004255 Butylated hydroxyanisole Substances 0.000 description 1
- POMXRTXXYBYTOJ-UHFFFAOYSA-N C(C)C(CCCCC(=O)O)(CC)CC.C(O)C(CC)(CO)CO Chemical compound C(C)C(CCCCC(=O)O)(CC)CC.C(O)C(CC)(CO)CO POMXRTXXYBYTOJ-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- 235000009025 Carya illinoensis Nutrition 0.000 description 1
- 244000068645 Carya illinoensis Species 0.000 description 1
- 241000283153 Cetacea Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 235000005979 Citrus limon Nutrition 0.000 description 1
- 244000131522 Citrus pyriformis Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 244000077995 Coix lacryma jobi Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- 229920000858 Cyclodextrin Polymers 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- CIWBSHSKHKDKBQ-DUZGATOHSA-N D-araboascorbic acid Natural products OC[C@@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-DUZGATOHSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- RDOFJDLLWVCMRU-UHFFFAOYSA-N Diisobutyl adipate Chemical compound CC(C)COC(=O)CCCCC(=O)OCC(C)C RDOFJDLLWVCMRU-UHFFFAOYSA-N 0.000 description 1
- SNRUBQQJIBEYMU-UHFFFAOYSA-N Dodecane Natural products CCCCCCCCCCCC SNRUBQQJIBEYMU-UHFFFAOYSA-N 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- LVGKNOAMLMIIKO-UHFFFAOYSA-N Elaidinsaeure-aethylester Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC LVGKNOAMLMIIKO-UHFFFAOYSA-N 0.000 description 1
- 102000016942 Elastin Human genes 0.000 description 1
- 108010014258 Elastin Proteins 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 244000061408 Eugenia caryophyllata Species 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- JZNWSCPGTDBMEW-UHFFFAOYSA-N Glycerophosphorylethanolamin Natural products NCCOP(O)(=O)OCC(O)CO JZNWSCPGTDBMEW-UHFFFAOYSA-N 0.000 description 1
- ZWZWYGMENQVNFU-UHFFFAOYSA-N Glycerophosphorylserin Natural products OC(=O)C(N)COP(O)(=O)OCC(O)CO ZWZWYGMENQVNFU-UHFFFAOYSA-N 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000019487 Hazelnut oil Nutrition 0.000 description 1
- 241000384508 Hoplostethus atlanticus Species 0.000 description 1
- SHBUUTHKGIVMJT-UHFFFAOYSA-N Hydroxystearate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OO SHBUUTHKGIVMJT-UHFFFAOYSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 241001072282 Limnanthes Species 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000017822 Melilotus officinalis Nutrition 0.000 description 1
- 240000000366 Melilotus officinalis Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 235000008708 Morus alba Nutrition 0.000 description 1
- 240000000249 Morus alba Species 0.000 description 1
- MMBILEWCGWTAOV-UHFFFAOYSA-N N-(2-Hydroxypropyl)dodecanamide Chemical compound CCCCCCCCCCCC(=O)NCC(C)O MMBILEWCGWTAOV-UHFFFAOYSA-N 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 241000772415 Neovison vison Species 0.000 description 1
- CHGJJXYCZVFOGE-UHFFFAOYSA-N Octan-2-yl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)CCCCCC CHGJJXYCZVFOGE-UHFFFAOYSA-N 0.000 description 1
- RJECHNNFRHZQKU-UHFFFAOYSA-N Oelsaeurecholesterylester Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCC=CCCCCCCCC)C2 RJECHNNFRHZQKU-UHFFFAOYSA-N 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000021319 Palmitoleic acid Nutrition 0.000 description 1
- 235000000370 Passiflora edulis Nutrition 0.000 description 1
- 244000288157 Passiflora edulis Species 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004347 Perilla Nutrition 0.000 description 1
- 244000124853 Perilla frutescens Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000972673 Phellodendron amurense Species 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical group CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 240000003946 Saponaria officinalis Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- 235000016639 Syzygium aromaticum Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 241000270666 Testudines Species 0.000 description 1
- BHEOSNUKNHRBNM-UHFFFAOYSA-N Tetramethylsqualene Natural products CC(=C)C(C)CCC(=C)C(C)CCC(C)=CCCC=C(C)CCC(C)C(=C)CCC(C)C(C)=C BHEOSNUKNHRBNM-UHFFFAOYSA-N 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- DOOTYTYQINUNNV-UHFFFAOYSA-N Triethyl citrate Chemical compound CCOC(=O)CC(O)(C(=O)OCC)CC(=O)OCC DOOTYTYQINUNNV-UHFFFAOYSA-N 0.000 description 1
- ZJCCRDAZUWHFQH-UHFFFAOYSA-N Trimethylolpropane Chemical compound CCC(CO)(CO)CO ZJCCRDAZUWHFQH-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-UHFFFAOYSA-N Trioleoylglycerol Natural products CCCCCCCCC=CCCCCCCCC(=O)OCC(OC(=O)CCCCCCCC=CCCCCCCCC)COC(=O)CCCCCCCC=CCCCCCCCC PHYFQTYBJUILEZ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000018936 Vitellaria paradoxa Nutrition 0.000 description 1
- 241001135917 Vitellaria paradoxa Species 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- XKMYWNHZAQUEPY-YZGJEOKZSA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 12-hydroxyoctadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCC(O)CCCCCC)C1 XKMYWNHZAQUEPY-YZGJEOKZSA-N 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- LDDUCKDUDZVHLN-UHFFFAOYSA-N [2-hydroxy-3-[2-hydroxy-3-(16-methylheptadecanoyloxy)propoxy]propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(O)COCC(O)COC(=O)CCCCCCCCCCCCCCC(C)C LDDUCKDUDZVHLN-UHFFFAOYSA-N 0.000 description 1
- DRRMRHKHTQRWMB-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-bis(2-ethylhexanoyloxymethyl)propyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(COC(=O)C(CC)CCCC)(COC(=O)C(CC)CCCC)COC(=O)C(CC)CCCC DRRMRHKHTQRWMB-UHFFFAOYSA-N 0.000 description 1
- GORMSINSWZJIKL-UHFFFAOYSA-N [3-(2-ethylhexanoyloxy)-2,2-dimethylpropyl] 2-ethylhexanoate Chemical compound CCCCC(CC)C(=O)OCC(C)(C)COC(=O)C(CC)CCCC GORMSINSWZJIKL-UHFFFAOYSA-N 0.000 description 1
- CMPDPBDUZTUXAD-UHFFFAOYSA-N [3-hydroxy-2-(16-methylheptadecanoyloxy)propyl] 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OCC(CO)OC(=O)CCCCCCCCCCCCCCC(C)C CMPDPBDUZTUXAD-UHFFFAOYSA-N 0.000 description 1
- VLSOAXRVHARBEQ-UHFFFAOYSA-N [4-fluoro-2-(hydroxymethyl)phenyl]methanol Chemical compound OCC1=CC=C(F)C=C1CO VLSOAXRVHARBEQ-UHFFFAOYSA-N 0.000 description 1
- ABKPAQVSXGDAOP-UHFFFAOYSA-N [5-(2,2-dimethylpropanoyloxy)-3-methylpentyl] 2,2-dimethylpropanoate Chemical compound CC(C)(C)C(=O)OCCC(C)CCOC(=O)C(C)(C)C ABKPAQVSXGDAOP-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000001361 adipic acid Substances 0.000 description 1
- 235000011037 adipic acid Nutrition 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229940069521 aloe extract Drugs 0.000 description 1
- RGZSQWQPBWRIAQ-LSDHHAIUSA-N alpha-Bisabolol Natural products CC(C)=CCC[C@@](C)(O)[C@@H]1CCC(C)=CC1 RGZSQWQPBWRIAQ-LSDHHAIUSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 1
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 229940064004 antiseptic throat preparations Drugs 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 235000013793 astaxanthin Nutrition 0.000 description 1
- MQZIGYBFDRPAKN-ZWAPEEGVSA-N astaxanthin Chemical compound C([C@H](O)C(=O)C=1C)C(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)C(=O)[C@@H](O)CC1(C)C MQZIGYBFDRPAKN-ZWAPEEGVSA-N 0.000 description 1
- 239000001168 astaxanthin Substances 0.000 description 1
- 229940022405 astaxanthin Drugs 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- IWWCATWBROCMCW-UHFFFAOYSA-N batyl alcohol Natural products CCCCCCCCCCCCCCCCCCOC(O)CO IWWCATWBROCMCW-UHFFFAOYSA-N 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 229940116224 behenate Drugs 0.000 description 1
- UKMSUNONTOPOIO-UHFFFAOYSA-M behenate Chemical compound CCCCCCCCCCCCCCCCCCCCCC([O-])=O UKMSUNONTOPOIO-UHFFFAOYSA-M 0.000 description 1
- 229940116226 behenic acid Drugs 0.000 description 1
- 229940050390 benzoate Drugs 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 229960004365 benzoic acid Drugs 0.000 description 1
- 229960004217 benzyl alcohol Drugs 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- 239000003833 bile salt Substances 0.000 description 1
- 229940093761 bile salts Drugs 0.000 description 1
- PKVYKIKWKPWIMO-UHFFFAOYSA-N bis(2-butyloctyl) decanedioate Chemical compound CCCCCCC(CCCC)COC(=O)CCCCCCCCC(=O)OCC(CCCC)CCCCCC PKVYKIKWKPWIMO-UHFFFAOYSA-N 0.000 description 1
- 229940036350 bisabolol Drugs 0.000 description 1
- HHGZABIIYIWLGA-UHFFFAOYSA-N bisabolol Natural products CC1CCC(C(C)(O)CCC=C(C)C)CC1 HHGZABIIYIWLGA-UHFFFAOYSA-N 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 description 1
- 239000010495 camellia oil Substances 0.000 description 1
- 239000004204 candelilla wax Substances 0.000 description 1
- 229940073532 candelilla wax Drugs 0.000 description 1
- 235000013868 candelilla wax Nutrition 0.000 description 1
- 229940007061 capsicum extract Drugs 0.000 description 1
- 239000001943 capsicum frutescens fruit extract Substances 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 150000001733 carboxylic acid esters Chemical class 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229940074979 cetyl palmitate Drugs 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- OOWQBDFWEXAXPB-UHFFFAOYSA-N chimyl alcohol Natural products CCCCCCCCCCCCCCCCOCC(O)CO OOWQBDFWEXAXPB-UHFFFAOYSA-N 0.000 description 1
- 235000012000 cholesterol Nutrition 0.000 description 1
- XHRPOTDGOASDJS-UHFFFAOYSA-N cholesterol n-octadecanoate Natural products C12CCC3(C)C(C(C)CCCC(C)C)CCC3C2CC=C2C1(C)CCC(OC(=O)CCCCCCCCCCCCCCCCC)C2 XHRPOTDGOASDJS-UHFFFAOYSA-N 0.000 description 1
- 229940072104 cholesteryl hydroxystearate Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- RJECHNNFRHZQKU-RMUVNZEASA-N cholesteryl oleate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCC\C=C/CCCCCCCC)C1 RJECHNNFRHZQKU-RMUVNZEASA-N 0.000 description 1
- XHRPOTDGOASDJS-XNTGVSEISA-N cholesteryl stearate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCCCC)C1 XHRPOTDGOASDJS-XNTGVSEISA-N 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- KXKPYJOVDUMHGS-OSRGNVMNSA-N chondroitin sulfate Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](OS(O)(=O)=O)[C@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](C(O)=O)O1 KXKPYJOVDUMHGS-OSRGNVMNSA-N 0.000 description 1
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 238000004581 coalescence Methods 0.000 description 1
- 229940110456 cocoa butter Drugs 0.000 description 1
- 235000019868 cocoa butter Nutrition 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 239000002385 cottonseed oil Substances 0.000 description 1
- 229940109239 creatinine Drugs 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 150000005690 diesters Chemical class 0.000 description 1
- 229940031769 diisobutyl adipate Drugs 0.000 description 1
- 229940031578 diisopropyl adipate Drugs 0.000 description 1
- 229940031569 diisopropyl sebacate Drugs 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- KWABLUYIOFEZOY-UHFFFAOYSA-N dioctyl butanedioate Chemical compound CCCCCCCCOC(=O)CCC(=O)OCCCCCCCC KWABLUYIOFEZOY-UHFFFAOYSA-N 0.000 description 1
- MIMDHDXOBDPUQW-UHFFFAOYSA-N dioctyl decanedioate Chemical compound CCCCCCCCOC(=O)CCCCCCCCC(=O)OCCCCCCCC MIMDHDXOBDPUQW-UHFFFAOYSA-N 0.000 description 1
- XFKBBSZEQRFVSL-UHFFFAOYSA-N dipropan-2-yl decanedioate Chemical compound CC(C)OC(=O)CCCCCCCCC(=O)OC(C)C XFKBBSZEQRFVSL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013345 egg yolk Nutrition 0.000 description 1
- 210000002969 egg yolk Anatomy 0.000 description 1
- 239000008344 egg yolk phospholipid Substances 0.000 description 1
- 229940068998 egg yolk phospholipid Drugs 0.000 description 1
- 229920002549 elastin Polymers 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 235000010350 erythorbic acid Nutrition 0.000 description 1
- 239000004318 erythorbic acid Substances 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 1
- LVGKNOAMLMIIKO-QXMHVHEDSA-N ethyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC LVGKNOAMLMIIKO-QXMHVHEDSA-N 0.000 description 1
- 229940093471 ethyl oleate Drugs 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229940100524 ethylhexylglycerin Drugs 0.000 description 1
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 1
- 229940007062 eucalyptus extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 239000010475 evening primrose oil Substances 0.000 description 1
- 229940089020 evening primrose oil Drugs 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 229960002442 glucosamine Drugs 0.000 description 1
- 229960002989 glutamic acid Drugs 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 229940100608 glycol distearate Drugs 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 229940038487 grape extract Drugs 0.000 description 1
- 229940065115 grapefruit extract Drugs 0.000 description 1
- 239000003676 hair preparation Substances 0.000 description 1
- 239000010468 hazelnut oil Substances 0.000 description 1
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 1
- PXDJXZJSCPSGGI-UHFFFAOYSA-N hexadecanoic acid hexadecyl ester Natural products CCCCCCCCCCCCCCCCOC(=O)CCCCCCCCCCCCCCC PXDJXZJSCPSGGI-UHFFFAOYSA-N 0.000 description 1
- XJNUECKWDBNFJV-UHFFFAOYSA-N hexadecyl 2-ethylhexanoate Chemical compound CCCCCCCCCCCCCCCCOC(=O)C(CC)CCCC XJNUECKWDBNFJV-UHFFFAOYSA-N 0.000 description 1
- 229940051250 hexylene glycol Drugs 0.000 description 1
- 235000020721 horse chestnut extract Nutrition 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229920006007 hydrogenated polyisobutylene Polymers 0.000 description 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 description 1
- 229940072106 hydroxystearate Drugs 0.000 description 1
- VJVOFLWZDWLHNR-MRCUWXFGSA-N icosan-9-yl (z)-docos-13-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCCCCCC\C=C/CCCCCCCC VJVOFLWZDWLHNR-MRCUWXFGSA-N 0.000 description 1
- HQRJTRSKPWEIII-OCANKYAHSA-N icosan-9-yl (z,12r)-12-hydroxyoctadec-9-enoate Chemical compound CCCCCCCCCCCC(CCCCCCCC)OC(=O)CCCCCCC\C=C/C[C@H](O)CCCCCC HQRJTRSKPWEIII-OCANKYAHSA-N 0.000 description 1
- 239000002563 ionic surfactant Substances 0.000 description 1
- 229940026239 isoascorbic acid Drugs 0.000 description 1
- 229940100554 isononyl isononanoate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 229940093629 isopropyl isostearate Drugs 0.000 description 1
- XUGNVMKQXJXZCD-UHFFFAOYSA-N isopropyl palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC(C)C XUGNVMKQXJXZCD-UHFFFAOYSA-N 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 229940031957 lauric acid diethanolamide Drugs 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 1
- 229960004488 linolenic acid Drugs 0.000 description 1
- 235000021388 linseed oil Nutrition 0.000 description 1
- 239000000944 linseed oil Substances 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000845 maltitol Substances 0.000 description 1
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 1
- 235000010449 maltitol Nutrition 0.000 description 1
- 229940035436 maltitol Drugs 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 239000004200 microcrystalline wax Substances 0.000 description 1
- 235000019808 microcrystalline wax Nutrition 0.000 description 1
- 229940114937 microcrystalline wax Drugs 0.000 description 1
- 235000021243 milk fat Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- FBUKVWPVBMHYJY-UHFFFAOYSA-N noncarboxylic acid Natural products CCCCCCCCC(O)=O FBUKVWPVBMHYJY-UHFFFAOYSA-N 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 235000019488 nut oil Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 239000007764 o/w emulsion Substances 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- KSCKTBJJRVPGKM-UHFFFAOYSA-N octan-1-olate;titanium(4+) Chemical compound [Ti+4].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-].CCCCCCCC[O-] KSCKTBJJRVPGKM-UHFFFAOYSA-N 0.000 description 1
- OAQWWRSICWQQSE-UHFFFAOYSA-N octan-2-yl 16-methylheptadecanoate Chemical compound CCCCCCC(C)OC(=O)CCCCCCCCCCCCCCC(C)C OAQWWRSICWQQSE-UHFFFAOYSA-N 0.000 description 1
- MIEBBHYETAOCSS-UHFFFAOYSA-N octan-2-yl dodecanoate Chemical compound CCCCCCCCCCCC(=O)OC(C)CCCCCC MIEBBHYETAOCSS-UHFFFAOYSA-N 0.000 description 1
- LKKNEKWLXFNDDM-UHFFFAOYSA-N octan-2-yl tetradecanoate Chemical compound CCCCCCCCCCCCCC(=O)OC(C)CCCCCC LKKNEKWLXFNDDM-UHFFFAOYSA-N 0.000 description 1
- YPMOZWCBANATQH-UHFFFAOYSA-N octyl 7-methyloctanoate Chemical compound CCCCCCCCOC(=O)CCCCCC(C)C YPMOZWCBANATQH-UHFFFAOYSA-N 0.000 description 1
- 229940073665 octyldodecyl myristate Drugs 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 229920002601 oligoester Polymers 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 125000006353 oxyethylene group Chemical group 0.000 description 1
- 239000003002 pH adjusting agent Substances 0.000 description 1
- 239000003346 palm kernel oil Substances 0.000 description 1
- 235000019865 palm kernel oil Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229950007031 palmidrol Drugs 0.000 description 1
- HXYVTAGFYLMHSO-UHFFFAOYSA-N palmitoyl ethanolamide Chemical compound CCCCCCCCCCCCCCCC(=O)NCCO HXYVTAGFYLMHSO-UHFFFAOYSA-N 0.000 description 1
- 125000000913 palmityl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 229940117336 parsley extract Drugs 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 235000020737 peppermint extract Nutrition 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 235000019271 petrolatum Nutrition 0.000 description 1
- WVDDGKGOMKODPV-ZQBYOMGUSA-N phenyl(114C)methanol Chemical compound O[14CH2]C1=CC=CC=C1 WVDDGKGOMKODPV-ZQBYOMGUSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- WTJKGGKOPKCXLL-RRHRGVEJSA-N phosphatidylcholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCC=CCCCCCCCC WTJKGGKOPKCXLL-RRHRGVEJSA-N 0.000 description 1
- 150000008104 phosphatidylethanolamines Chemical class 0.000 description 1
- 150000003905 phosphatidylinositols Chemical class 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920001083 polybutene Polymers 0.000 description 1
- 229920000223 polyglycerol Polymers 0.000 description 1
- 238000006116 polymerization reaction Methods 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- NEOZOXKVMDBOSG-UHFFFAOYSA-N propan-2-yl 16-methylheptadecanoate Chemical compound CC(C)CCCCCCCCCCCCCCC(=O)OC(C)C NEOZOXKVMDBOSG-UHFFFAOYSA-N 0.000 description 1
- 235000013772 propylene glycol Nutrition 0.000 description 1
- 229940010310 propylene glycol dioleate Drugs 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000010667 rosehip oil Substances 0.000 description 1
- 229940092258 rosemary extract Drugs 0.000 description 1
- 235000020748 rosemary extract Nutrition 0.000 description 1
- 239000001233 rosmarinus officinalis l. extract Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- WVYADZUPLLSGPU-UHFFFAOYSA-N salsalate Chemical compound OC(=O)C1=CC=CC=C1OC(=O)C1=CC=CC=C1O WVYADZUPLLSGPU-UHFFFAOYSA-N 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 235000017709 saponins Nutrition 0.000 description 1
- 108700004121 sarkosyl Proteins 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- HFHDHCJBZVLPGP-UHFFFAOYSA-N schardinger α-dextrin Chemical compound O1C(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC(C(O)C2O)C(CO)OC2OC(C(C2O)O)C(CO)OC2OC2C(O)C(O)C1OC2CO HFHDHCJBZVLPGP-UHFFFAOYSA-N 0.000 description 1
- 229940116351 sebacate Drugs 0.000 description 1
- CXMXRPHRNRROMY-UHFFFAOYSA-L sebacate(2-) Chemical compound [O-]C(=O)CCCCCCCCC([O-])=O CXMXRPHRNRROMY-UHFFFAOYSA-L 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 239000003352 sequestering agent Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 229940057910 shea butter Drugs 0.000 description 1
- 230000036548 skin texture Effects 0.000 description 1
- 229940001482 sodium sulfite Drugs 0.000 description 1
- 235000010265 sodium sulphite Nutrition 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 229940031439 squalene Drugs 0.000 description 1
- TUHBEKDERLKLEC-UHFFFAOYSA-N squalene Natural products CC(=CCCC(=CCCC(=CCCC=C(/C)CCC=C(/C)CC=C(C)C)C)C)C TUHBEKDERLKLEC-UHFFFAOYSA-N 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 229940012831 stearyl alcohol Drugs 0.000 description 1
- 125000004079 stearyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- 239000001069 triethyl citrate Substances 0.000 description 1
- VMYFZRTXGLUXMZ-UHFFFAOYSA-N triethyl citrate Natural products CCOC(=O)C(O)(C(=O)OCC)C(=O)OCC VMYFZRTXGLUXMZ-UHFFFAOYSA-N 0.000 description 1
- 235000013769 triethyl citrate Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- 229940098385 triisostearin Drugs 0.000 description 1
- VLPFTAMPNXLGLX-UHFFFAOYSA-N trioctanoin Chemical compound CCCCCCCC(=O)OCC(OC(=O)CCCCCCC)COC(=O)CCCCCCC VLPFTAMPNXLGLX-UHFFFAOYSA-N 0.000 description 1
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 1
- 229940117972 triolein Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Cosmetics (AREA)
Abstract
Description
本発明は、半透明乃至透明の皮膚外用剤に関し、特に、透明乃至半透明の可溶化系に固形乃至半固形の油剤を配合した安定性の向上した皮膚外用剤である。 TECHNICAL FIELD The present invention relates to a translucent or transparent external preparation for skin, and in particular, an external preparation for skin with improved stability, which is obtained by blending a solid or semi-solid oil agent in a transparent or translucent solubilized system.
透明乃至半固形の皮膚外用剤は、補水・保湿を目的に各種保湿剤を水に溶解し、皮膚角層に潤いを与えるものである。しかしながら、肌理(キメ)の改善効果を付与するには水分の蒸散を防ぐことが必須であるのに対して、皮膚の角層に与えられた水分は時間の経過と共に蒸散し、肌理の改善効果が期待できないものであった。そのため、油中水型(O/W型)エマルションを希釈した剤型等が用いられているが、熱力学的に不安定なものであり、使用感触的にもベタツキ、さっぱりしない等の使用性面での不都合があった。 A transparent or semi-solid external preparation for skin is one in which various moisturizing agents are dissolved in water for the purpose of water replenishment and moisturizing, and the stratum corneum of the skin is moisturized. However, while it is essential to prevent evaporation of moisture in order to impart the effect of improving texture, moisture given to the stratum corneum of the skin evaporates over time, resulting in the effect of improving texture. was not expected. For this reason, formulations prepared by diluting water-in-oil (O/W) emulsions have been used, but they are thermodynamically unstable and have good usability, such as stickiness and a lack of freshness. I had a problem with the face.
そこで、この問題を解決するためには、閉塞性の高い油剤、具体的には固形乃至半固形油を使用することが望ましい。例えば、角層の保湿やバリア機能向上を目的として、特許文献1には、重合度3~7ポリグリセリン炭素数10~22の脂肪酸モノエステルと脂肪酸ジグリセリンと飽和二塩基酸とのジエステルとスクワラン、ミツロウ(固形ワックス)、ホホバ油を配合した水中油型マイクロエマルションが開示されている。また、特許文献2には、分岐脂肪酸フィトステリルと炭素数10~22脂肪酸トリグリセリドとスクワラン、ミツロウ(固形ワックス)、ホホバ油を配合構造組成物が開示されている。 Therefore, in order to solve this problem, it is desirable to use highly clogging oils, specifically solid or semi-solid oils. For example, for the purpose of moisturizing the stratum corneum and improving the barrier function, Patent Document 1 discloses polyglycerol with a degree of polymerization of 3 to 7, a diester of a fatty acid monoester with a carbon number of 10 to 22, a fatty acid diglycerin, and a saturated dibasic acid, and squalane. , beeswax (solid wax), and jojoba oil are disclosed. Further, Patent Document 2 discloses a structural composition containing branched fatty acid phytosteryl, fatty acid triglyceride with 10 to 22 carbon atoms, squalane, beeswax (solid wax), and jojoba oil.
さらに、特許文献3には、熱力学的に不安定な油中水型(O/W型)エマルションの製造方法として、常温で液状の油剤と水素添加リン脂質(HLB:9~16)の非イオン界面活性剤と2価のグリコール類と水を含有する白濁状水中油型(O/W型)エマルションの開示がされている。 Furthermore, in Patent Document 3, as a method for producing a thermodynamically unstable water-in-oil type (O / W type) emulsion, a liquid oil at room temperature and a hydrogenated phospholipid (HLB: 9 to 16) A cloudy oil-in-water (O/W) emulsion containing an ionic surfactant, divalent glycols and water is disclosed.
しかしながら、特許文献1および特許文献2記載の技術は、界面活性剤である乳化物のベタツキにより、さっぱりした感触を得ることができなかった。また、エマルションであるため、経時的な油滴の合一等は避けられず、油滴の経時安定性を十分に得られるものではなかった。 However, the techniques described in Patent Documents 1 and 2 cannot provide a refreshing feel due to the stickiness of the surfactant emulsion. In addition, since it is an emulsion, coalescence of oil droplets over time cannot be avoided, and sufficient stability over time of oil droplets cannot be obtained.
また、特許文献3には、さっぱりとした使用感を付与するために、白濁状水中油型(O/W型)の低粘度でも安定な化粧水と乳液を1つにしたものの製造方法が開示しているが、常温で液状の油剤の配合が必須であることから特許文献1や特許文献2のような皮膚の改善効果は少なく、その改善が望まれていた。 In addition, Patent Document 3 discloses a method for producing a white turbid oil-in-water type (O/W type) lotion that is stable even with a low viscosity and a milky lotion in one, in order to provide a refreshing feeling in use. However, since it is essential to incorporate an oil agent that is liquid at room temperature, it does not have the skin-improving effect of Patent Documents 1 and 2, and its improvement has been desired.
そこで、本発明の目的は、前記の従来技術の問題点を解決し、透明乃至半透明の可溶化系に固形乃至半固形の油剤を配合した安定性の向上した皮膚外用剤を得ることである。 SUMMARY OF THE INVENTION Accordingly, an object of the present invention is to solve the above-mentioned problems of the prior art, and to obtain an external preparation for skin with improved stability by blending a solid or semi-solid oil in a transparent or translucent solubilized system. .
本発明者らは、前記課題を解決すべく鋭意検討を行った結果、固形乃至半固形の油剤と特定の界面活性剤を組合せることによって、前記目的を達成し得ることを見出し、本発明を完成するに至った。 The inventors of the present invention conducted intensive studies to solve the above problems, and found that the above objects can be achieved by combining a solid or semi-solid oil with a specific surfactant. Completed.
即ち、本発明の半透明乃至透明の皮膚外用剤は、
(A)固形乃至半固形の油剤と、
(B)常温で液状の炭化水素の油剤と、
(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)と、
(D)炭素数が18~22の高級アルコールと、
(E)多価アルコールと、
(F)水と、を有することを特徴とするものである。ここで、(1~40 E.O.)とは、オキシエチレンの付加モル数が1~40であること示し、(1~30 P.O.)とは、オキシプロピレンの付加モル数が1~30であること示し、(C16~C24)とは、アルキル基の炭素数が16~24であること示す。
That is, the translucent or transparent external preparation for skin of the present invention is
(A) a solid or semi-solid oil,
(B) a hydrocarbon oil that is liquid at room temperature;
(C) polyoxyethylenated (1-40 E.O.) and polyoxypropylenated (1-30 P.O.) alkyl (C16-C24);
(D) a higher alcohol having 18 to 22 carbon atoms;
(E) a polyhydric alcohol;
and (F) water. Here, (1 to 40 E.O.) means that the number of added moles of oxyethylene is 1 to 40, and (1 to 30 PO) means that the number of added moles of oxypropylene is 1. 30, and (C16-C24) indicates that the number of carbon atoms in the alkyl group is 16-24.
また、本発明の半透明乃至透明の皮膚外用剤は、(G)ポリオキシエチレン水添ヒマシ油を有し、前記(G)ポリオキシエチレン水添ヒマシ油が、PEG-5水添ヒマシ油、PEG-10水添ヒマシ油、PEG-20水添ヒマシ油、PEG-30水添ヒマシ油、PEG-40水添ヒマシ油、PEG-50水添ヒマシ油、PEG-60水添ヒマシ油、PEG-80水添ヒマシ油およびPEG-100水添ヒマシ油からなる群から選ばれる1種または2種以上であることが、好ましい。 Further, the translucent or transparent external preparation for skin of the present invention has (G) polyoxyethylene hydrogenated castor oil, and the (G) polyoxyethylene hydrogenated castor oil is PEG-5 hydrogenated castor oil, PEG-10 hydrogenated castor oil, PEG-20 hydrogenated castor oil, PEG-30 hydrogenated castor oil, PEG-40 hydrogenated castor oil, PEG-50 hydrogenated castor oil, PEG-60 hydrogenated castor oil, PEG- It is preferably one or more selected from the group consisting of 80 hydrogenated castor oil and PEG-100 hydrogenated castor oil.
さらに、本発明の半透明乃至透明の皮膚外用剤は、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)が、PPG-6デシルテトラデセス-30、PPG-6デシルテトラデセス-12、PPG―13デシルテトラデセス-24、PPG-6デシルテトラデセス-20、PPG-4セテス-1、PPG-8セテス-1、PPG-4セテス-10、PPG-4セテス-20、PPG-5セテス-20、PPG-8セテス-20およびPPG-23ステアレス-34からなる群から選ばれる1種または2種以上であることが、好ましい。 Furthermore, the translucent to transparent external preparation for skin of the present invention contains (C) polyoxyethylenated (1 to 40 E.O.) and polyoxypropylenated (1 to 30 P.O.) alkyl (C16 to C24) is PPG-6 decyltetradeceth-30, PPG-6 decyltetradeceth-12, PPG-13 decyltetradeceth-24, PPG-6 decyltetradeceth-20, PPG-4 ceteth-1 , PPG-8 ceteth-1, PPG-4 ceteth-10, PPG-4 ceteth-20, PPG-5 ceteth-20, PPG-8 ceteth-20 and PPG-23 steareth-34 Or it is preferable that they are 2 or more types.
本発明によると、透明乃至半透明の可溶化系に固形乃至半固形の油剤を配合した安定性の向上した皮膚外用剤を提供することができる。 According to the present invention, it is possible to provide an external preparation for skin with improved stability in which a solid or semi-solid oil agent is blended with a transparent or translucent solubilized system.
以下、本発明の半透明乃至透明の皮膚外用剤について具体的に説明する。
本発明の半透明乃至透明の皮膚外用剤は、(A)固形乃至半固形の油剤と、(B)常温で液状の炭化水素の油剤と、(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)と、(D)炭素数が18~22の高級アルコールと、(E)多価アルコールと、(F)水と、を有することを特徴とするものである。外観は、透明乃至半透明を呈する可溶化系の皮膚外用剤で、皮膚の肌理(キメ)改善効果を有し、ベタツキのないさっぱりとした使用性を有するものである。また、熱力学的に安定な可溶化領域にて、常温で固形乃至半固形の閉塞効果が高い油剤を配合することで肌改善効果が向上し、かつ、べたつきがなくさっぱりした使用感が向上した皮膚外用剤である。なお、本発明における半透明乃至透明とは、目視による観察だけでなく、透明とは、明度(L*a*b*表色系におけるL値)が99.0以上、より好ましくは99.4以上である状態を指し、半透明とは、1~99である状態を指す。また、明度とは、色の属性の一つであり、その色の明暗の度合いがを0.0から100.0までで表され、L値が上昇するに従って、より透明となる。測定は、分光色彩計等により測定することができるが、その他の通常の明度を測定できる方法であれば特に限定されない。例えば、分光光度計を用い、ガラスセルに精製水5mLを入れて光を透過させたときの透明度を100とし、光を完全に遮断して透過光がないときの透明度を0として測定することができる。
Hereinafter, the translucent or transparent external preparation for skin of the present invention will be specifically described.
The translucent or transparent external preparation for skin of the present invention comprises (A) a solid or semi-solid oil, (B) a hydrocarbon oil that is liquid at room temperature, and (C) a polyoxyethylenated (1 to 40 E. O.) and polyoxypropylenated (1-30 P.O.) alkyl (C16-C24), (D) a higher alcohol having 18 to 22 carbon atoms, (E) a polyhydric alcohol, and (F) and water. It is a solubilized external preparation for skin that is transparent or translucent in appearance, has the effect of improving skin texture, and has refreshing usability without stickiness. In addition, in the thermodynamically stable solubilization region, by blending an oil that is solid or semi-solid at room temperature and has a high occlusive effect, the skin improvement effect is improved, and the feeling of use is improved without stickiness and refreshing. It is an external skin preparation. In addition, translucent or transparent in the present invention means not only visual observation, but also means that the lightness (L * a * b * L value in the color system) is 99.0 or more, more preferably 99.4. It refers to a state of 1 to 99, and translucent refers to a state of 1 to 99. Lightness is one of the attributes of color, and the degree of lightness and darkness of the color is expressed from 0.0 to 100.0. As the L value increases, the transparency becomes more transparent. The measurement can be performed with a spectrocolorimeter or the like, but is not particularly limited as long as it is another method that can measure the normal brightness. For example, using a spectrophotometer, the transparency when 5 mL of purified water is put in a glass cell and light is transmitted is set to 100, and the transparency when the light is completely blocked and no light is transmitted can be measured as 0. can.
本発明において、前記(A)固形乃至半固形の油剤とは、融点が常温(20~25℃程度)以上の油分を意味するものであり、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されない。かかる(A)固形乃至半固形の油剤としては、例えば、閉塞性の高いオゾケライト、セレシン、マイクロクリスタリンワックス、ワセリン、キャンデリラロウ炭化水素、ビーズワックス、マンゴバター、ヤシ油、パーム油、パーム核油、カカオ脂、シア脂、水素添加ヤシ油、牛脂、乳脂、馬脂、鯨ロウ、ラノリン、還元ラノリン、吸着精製ラノリン、酢酸ラノリン、ラノリン脂肪酸、硬質ラノリン脂肪酸、ラノリンアルコール、レシチン(30℃、常温ペースト)、ホスファチジルコリン、ホスファチジルエタノールアミン、ホスファチジルセリン、ホスファチジルイノシトール、スフィンゴミエリン等のスフィンゴリン脂質、リゾレシチン等のリン脂質類、水素添加大豆リン脂質、部分水素添加大豆リン脂質、水素添加卵黄リン脂質、コレステロール、ジヒドロコレステロール、フィトステロール、コール酸等のステロール類、サポゲニン類、サポニン類、ステアリン酸コレステリル、イソステアリン酸コレステリル、オレイン酸コレステリル、N-ラウロイル-L-グルタミン酸ジ(コレステリル/ベヘニル/オクチルドデシル)、N-ラウロイル-L-グルタミン酸ジ(フィトステリル/ベヘニル/2-オクチルドデシル)、ヒドロキシステアリン酸コレステリル、マカデミアナッツ油脂肪酸コレステリル、マカデミアナッツ油脂肪酸フィトステリル、軟質ラノリン脂肪酸コレステリル、硬質ラノリン脂肪酸コレステリル、長鎖分岐脂肪酸コレステリル、ノナン酸コレステリル、軟質ラノリン脂肪酸コレステリル、硬質ラノリン脂肪酸コレステリル、長鎖分岐脂肪酸コレステリル、ラノリン脂肪酸オクチルドデシル、パルミチン酸セチル、イソステアリン酸硬化ヒマシ油、ラノリン脂肪酸イソプロピル、乳酸セチル、イソステアリン酸水添ヒマシ油ペースト、トリ水添ロジン酸グリセリル、(ベヘン酸/エイコサン二酸)グリセリル、ヘキサ(ヒドロキシステアリン酸/ステアリン酸/ロジン酸)ジペンタエリスリチル、ジステアリン酸グリコール(ジステアリン酸エチレングリコール)、ダイマージリノール酸(フィトステリル/イソステアリル/セチル/ステアリル/ベヘニル)、ダイマージリノール酸ダイマージリノレイル、ダイマージリノレイル水添ロジン縮合物、ダイマージリノール酸硬化ヒマシ油、ヒドロキシアルキル(C16-18)ヒドロキシダイマージリノレイルエーテル等のダイマー酸若しくはダイマージオールの誘導体、セタノール、ミリスチルアルコール、ラウリルアルコール、セトステアリルアルコール、ステアリルアルコール、アラキジルアルコール、ベヘニルアルコール、キミルアルコール、バチルアルコール、ラウリン酸、ミリスチン酸、パルミチン酸 、ステアリン酸、ベヘン酸、12-ヒドロキシステアリン酸、ヤシ油脂肪酸モノエタノールアミド(コカミドMEA)、ラウリン酸モノイソプロパノールアミド(ラウラミドMIPA)、パルミチン酸モノエタノールアミド(パルタミドMEA)等を挙げることができる。 In the present invention, the (A) solid or semi-solid oil means an oil having a melting point of room temperature (approximately 20 to 25° C.) or higher, and can be used in ordinary skin preparations for external use. is not particularly limited as long as it is obtained. Examples of (A) solid or semi-solid oils include highly occlusive ozokerite, ceresin, microcrystalline wax, petrolatum, candelilla wax hydrocarbons, beeswax, mango butter, coconut oil, palm oil, and palm kernel oil. , cocoa butter, shea butter, hydrogenated coconut oil, beef tallow, milk fat, horse fat, whale wax, lanolin, reduced lanolin, adsorbed purified lanolin, lanolin acetate, lanolin fatty acid, hard lanolin fatty acid, lanolin alcohol, lecithin (30°C, normal temperature) paste), phosphatidylcholine, phosphatidylethanolamine, phosphatidylserine, phosphatidylinositol, sphingophospholipids such as sphingomyelin, phospholipids such as lysolecithin, hydrogenated soybean phospholipids, partially hydrogenated soybean phospholipids, hydrogenated egg yolk phospholipids, cholesterol , dihydrocholesterol, phytosterol, sterols such as cholic acid, sapogenins, saponins, cholesteryl stearate, cholesteryl isostearate, cholesteryl oleate, N-lauroyl-L-glutamate di(cholesteryl/behenyl/octyldodecyl), N- lauroyl-L-glutamic acid di(phytosteryl/behenyl/2-octyldodecyl), cholesteryl hydroxystearate, macadamia nut oil fatty acid cholesteryl, macadamia nut oil fatty acid phytosteryl, soft lanolin fatty acid cholesteryl, hard lanolin fatty acid cholesteryl, long-chain branched fatty acid cholesteryl, nonanoic acid Cholesteryl, soft lanolin fatty acid cholesteryl, hard lanolin fatty acid cholesteryl, long-chain branched fatty acid cholesteryl, lanolin fatty acid octyldodecyl, cetyl palmitate, hydrogenated castor oil isostearate, isopropyl lanolin fatty acid, cetyl lactate, hydrogenated castor oil isostearate paste, chicken water Glyceryl rosinate, glyceryl (behenate/eicosanedioate), hexa(hydroxystearate/stearate/rosinate) dipentaerythrityl, glycol distearate (ethylene glycol distearate), dimer dilinoleate (phytosteryl/isostearyl/cetyl) /stearyl/behenyl), dimer dilinoleyl dimer dilinoleate, hydrogenated rosin condensate of dimer dilinoleyl, hydrogenated castor oil of dimer dilinoleate, hydroxyalkyl (C16-18) hydroxy dimer dilinoleyl ether, etc. or Derivatives of dimer diol, cetanol, myristyl alcohol, lauryl alcohol, cetostearyl alcohol, stearyl alcohol, arachidyl alcohol, behenyl alcohol, chimyl alcohol, batyl alcohol, lauric acid, myristic acid, palmitic acid, stearic acid, behenic acid, 12- Hydroxystearic acid, coconut oil fatty acid monoethanolamide (cocamide MEA), lauric acid monoisopropanolamide (lauramide MIPA), palmitic acid monoethanolamide (partamide MEA) and the like can be mentioned.
また、本発明において、前記(B)常温で液状の炭化水素の油剤としては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されない。かかる(B)常温で液状の炭化水素の油剤としては、例えば、流動パラフィン(ミネラルオイル)、重質流動イソパラフィン、軽質流動イソパラフィン、α-オレフィンオリゴマー、ポリイソブテン、水添ポリイソブテン、ポリブテン、スクワラン、オリーブ由来スクワラン、スクワレン等を挙げることができる。なお、本発明において、「常温」とは、いわゆる一般的な室内の温度(室温)であり、例えば、20~25℃の温度範囲を示す。 In the present invention, the (B) hydrocarbon oil that is liquid at room temperature is not particularly limited as long as it can be used in ordinary skin preparations for external use and the effects of the present invention can be obtained. Examples of such (B) hydrocarbon oils that are liquid at room temperature include liquid paraffin (mineral oil), heavy liquid isoparaffin, light liquid isoparaffin, α-olefin oligomers, polyisobutene, hydrogenated polyisobutene, polybutene, squalane, and olive-derived oils. Squalane, squalene and the like can be mentioned. In the present invention, "ordinary temperature" means a so-called general indoor temperature (room temperature), and indicates a temperature range of 20 to 25°C, for example.
さらに、本発明において、本発明の効果を得ることができれば、前記(B)常温で液状の炭化水素の油剤以外の液状の油剤をいっしょに配合することができる。かかる(B)常温で液状の炭化水素の油剤以外の油剤としては、例えば、サフラワー油、オリーブ油、ヒマシ油、アボカド油、ゴマ油、茶油、月見草油、小麦胚芽油、マカデミアナッツ油、ヘーゼルナッツ油、ククイナッツ油、ローズヒップ油、メドウフォーム油、パーシック油、ティートリー油、ハッカ油、トウモロコシ油、ナタネ油、ヒマワリ油、小麦胚芽油、アマニ油、綿実油、大豆油、落花生油、コメヌカ油、水素添加ヒマシ油、ホホバ油、水素添加ホホバ油等の植物油脂類、卵黄油、ミンク油、タートル油等の動物性油脂類、オレンジラッフィー油、液状ラノリン、酢酸液状ラノリン、N-ラウロイル-L-グルタミン酸ジ(コレステリル/オクチルドデシル)、N-ラウロイル-L-グルタミン酸ジ(フィトステリル/オクチルドデシル)、N-ラウロイルサルコシンイソプロピル等のアシルサルコシンアルキルエステル、イソステアリン酸フィトステリル、ミリスチン酸オクチルドデシル、ミリスチン酸2-ヘキシルデシル、イソステアリン酸オクチルドデシル、2-エチルヘキサン酸セチル、エチルヘキサン酸ヘキシルデシル、イソノナン酸イソトリデシル、イソノナン酸イソノニル、イソノナン酸オクチル、イソノナン酸イソトリデシル、ネオペンタン酸イソデシル、ネオペンタン酸イソステアリル、オレイン酸オレイル、オレイン酸オクチルドデシル、リシノレイン酸オクチルドデシルエルカ酸オクチルドデシル、オレイン酸エチル、アボカド油脂肪酸エチル、ミリスチン酸イソプロピル、パルミチン酸イソプロピル、パルミチン酸オクチル、イソステアリン酸イソプロピル、ラウリン酸メチルヘプチル、ミリスチン酸メチルヘプチル、パルミチン酸メチルヘプチル、イソステアリン酸メチルヘプチル、セバシン酸ジエチル、セバシン酸ジイソプロピル、セバシン酸ジオクチル、アジピン酸ジイソプロピル、セバシン酸ジブチルオクチル、アジピン酸ジイソブチル、コハク酸ジオクチル、クエン酸トリエチル等のモノアルコールカルボン酸エステル類、リンゴ酸ジイソステアリル、トリオクタン酸グリセリル、トリオレイン酸グリセリル、トリイソステアリン酸グリセリル、ジイソステアリン酸グリセリル、トリ(カプリル酸/カプリン酸)グリセリル、トリ(カプリル酸/カプリン酸/ミリスチン酸/ステアリン酸)グリセリル、トリエチルヘキサン酸トリメチロールプロパン、トリイソステアリン酸トリメチロールプロパン、ジエチルヘキサン酸ネオペンチルグリコール、ジカプリン酸ネオペンチルグリコール、ジオレイン酸プロピレングリコール、テトラエチルヘキサン酸ペンタエリスリチル、(イソステアリン酸/セバシン酸)ジトリメチロールプロパンオリゴエステル、ジイソステアリン酸ジグリセリル、テトライソステアリン酸ポリグリセリル-2、ノナイソステアリン酸ポリグリセリル-10、ジネオペンタン酸メチルペンタンジオール、ダイマージリノール酸ジイソステアリル、ダイマージリノール酸ジ(イソステアリル/フィトステリル)、ジイソステアリン酸ダイマージリノレイル、オレイルアルコール、ホホバアルコール、オレイルグリセリル、ヘキシルデカノール、イソステアリルアルコール、2-オクチルドデカノール、ダイマージオール等の高級アルコール類、ベンジルアルコール等のアラルキルアルコール及び誘導体、イソステアリン酸、パルミトオレイン酸、オレイン酸、リノール酸、リノレン酸、イソヘキサデカン酸、ヤシ油脂肪酸ジエタノールアミド(コカミドDEA)、ラウリン酸ジエタノールアミド(ラウラミドDEA)、ヤシ油脂肪酸メチルエタノールアミド(コカミドメチルMEA)等の脂肪酸アルカノールアミド類等を挙げることができる。 Furthermore, in the present invention, if the effects of the present invention can be obtained, a liquid oil other than (B) the hydrocarbon oil that is liquid at room temperature can be blended together. Examples of (B) oils other than hydrocarbon oils that are liquid at room temperature include safflower oil, olive oil, castor oil, avocado oil, sesame oil, tea oil, evening primrose oil, wheat germ oil, macadamia nut oil, hazelnut oil, Kukui nut oil, rosehip oil, meadowfoam oil, persic oil, tea tree oil, peppermint oil, corn oil, rapeseed oil, sunflower oil, wheat germ oil, linseed oil, cottonseed oil, soybean oil, peanut oil, rice bran oil, hydrogenated castor vegetable oils such as jojoba oil and hydrogenated jojoba oil, animal oils such as egg yolk oil, mink oil, turtle oil, orange roughy oil, liquid lanolin, acetic acid liquid lanolin, N-lauroyl-L-glutamic acid di (cholesteryl/octyldodecyl), N-lauroyl-L-glutamic acid di(phytosteryl/octyldodecyl), N-lauroylsarcosine alkyl esters such as isopropyl, phytosteryl isostearate, octyldodecyl myristate, 2-hexyldecyl myristate, Octyldodecyl isostearate, cetyl 2-ethylhexanoate, hexyldecyl ethylhexanoate, isotridecyl isononanoate, isononyl isononanoate, octyl isononanoate, isotridecyl isononanoate, isodecyl neopentanoate, isostearyl neopentanoate, oleyl oleate, octyl oleate Dodecyl, octyldodecyl ricinoleate, octyldodecyl erucate, ethyl oleate, ethyl avocado oil, isopropyl myristate, isopropyl palmitate, octyl palmitate, isopropyl isostearate, methylheptyl laurate, methylheptyl myristate, methylheptyl palmitate , methylheptyl isostearate, diethyl sebacate, diisopropyl sebacate, dioctyl sebacate, diisopropyl adipate, dibutyloctyl sebacate, diisobutyl adipate, dioctyl succinate, monoalcohol carboxylic acid esters such as triethyl citrate, dimalic acid Isostearyl, Glyceryl Trioctanoate, Glyceryl Trioleate, Glyceryl Triisostearate, Glyceryl Diisostearate, Caprylic/Capric Triglyceryl, Caprylic/Capric/Myristic/Stearic Triglyceryl, Triethylhexanoic Acid trimethylolpropane, triisostearin trimethylolpropane acid, neopentyl glycol diethylhexanoate, neopentyl glycol dicaprate, propylene glycol dioleate, pentaerythrityl tetraethylhexanoate, (isostearate/sebacate) ditrimethylolpropane oligoester, diglyceryl diisostearate, tetraisostearin Polyglyceryl-2 acid, polyglyceryl-10 nonisostearate, methyl pentanediol dineopentanoate, diisostearyl dimer dilinoleate, di(isostearyl/phytosteryl) dimer dilinoleate, dimer dilinoleyl diisostearate, oleyl alcohol, jojoba alcohol , oleylglyceryl, hexyldecanol, isostearyl alcohol, 2-octyldodecanol, higher alcohols such as dimer diol, aralkyl alcohols and derivatives such as benzyl alcohol, isostearic acid, palmitoleic acid, oleic acid, linoleic acid, linolenic acid, Fatty acid alkanolamides such as isohexadecanoic acid, coconut oil fatty acid diethanolamide (cocamide DEA), lauric acid diethanolamide (lauramide DEA), coconut oil fatty acid methylethanolamide (cocamide methyl MEA), and the like can be mentioned.
また、本発明において、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)としては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、PPG-6デシルテトラデセス-30、PPG-6デシルテトラデセス-12、PPG―13デシルテトラデセス-24、PPG-6デシルテトラデセス-20、PPG-4セテス-1、PPG-8セテス-1、PPG-4セテス-10、PPG-4セテス-20、PPG-5セテス-20、PPG-8セテス-20およびPPG-23ステアレス-34からなる群から選ばれる1種または2種以上であることが、好ましい。具体的には、日光ケミカルズ株式会社製のNIKKOL SG-DTD630(商品名)、NIKKOL PEN-4612(商品名)、NIKKOL SG-DTD620(商品名)、NIKKOL PBC―31(商品名)、NIKKOL PBC―33(商品名)、NIKKOL SG―C420(商品名)、NIKKOL PBC―44(商品名)等を挙げることができる。 In the present invention, the (C) polyoxyethylenated (1 to 40 E.O.) and polyoxypropylenated (1 to 30 P.O.) alkyl (C16 to C24) may be used for general skin external use. Although it is not particularly limited as long as it can be used as an agent and the effect of the present invention can be obtained, PPG-6 decyltetradeceth-30, PPG-6 decyltetradeceth-12, PPG-13 decyltetradeceth-24 , PPG-6 decyltetradeceth-20, PPG-4 ceteth-1, PPG-8 ceteth-1, PPG-4 ceteth-10, PPG-4 ceteth-20, PPG-5 ceteth-20, PPG-8 ceteth -20 and PPG-23 steareth-34, preferably one or more selected from the group consisting of steareth-34. Specifically, NIKKOL SG-DTD630 (trade name), NIKKOL PEN-4612 (trade name), NIKKOL SG-DTD620 (trade name), NIKKOL PBC-31 (trade name), NIKKOL PBC- manufactured by Nikko Chemicals Co., Ltd. 33 (trade name), NIKKOL SG-C420 (trade name), NIKKOL PBC-44 (trade name), and the like.
さらに、本発明において、前記(D)炭素数が18~22の高級アルコールは、前記(A)固形乃至半固形の油剤および前記(B)常温で液状の炭化水素の油剤の可溶化を向上することができる。かかる(D)炭素数が18~22の高級アルコールとしては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、例えば、ステアリルアルコール、セトステアリルアルコール、オレイルアルコール、ベヘニルアルコール、イソステアリルアルコール、ヘキシルデカノール、オクチルドデカノール、デシルテトラデカノール、アラキルアルコール、アラキジルアルコール、ベヘニルアルコール等を挙げることができる。これらの高級アルコールは単独で使用しても組み合わせて使用してもよい。 Furthermore, in the present invention, the (D) higher alcohol having 18 to 22 carbon atoms improves the solubilization of the (A) solid or semi-solid oil agent and the (B) hydrocarbon oil agent that is liquid at room temperature. be able to. The (D) higher alcohol having 18 to 22 carbon atoms is not particularly limited as long as it can be used in ordinary external preparations for skin and the effects of the present invention can be obtained. Examples include stearyl alcohol, cetostearyl alcohol, Oleyl alcohol, behenyl alcohol, isostearyl alcohol, hexyldecanol, octyldodecanol, decyltetradecanol, arachyl alcohol, arachidyl alcohol, behenyl alcohol and the like can be mentioned. These higher alcohols may be used alone or in combination.
さらにまた、本発明において、前記(E)多価アルコールは界面活性剤の可溶可能を向上し、特に、2価の多価アルコールは皮膚角層の保湿感を向上することができる。かかる(E)多価アルコールとしては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、例えば、グリセリン、1,3-ブチレングリコール、プロピレングリコール、イソペンチルジオール、ジグリセリン、ソルビトール、ヘキシレングリコール、ペンチレングリコール、ポリエチレングリコール等を挙げることができる。これらの(E)多価アルコールは単独で使用しても組み合わせて使用してもよい。 Furthermore, in the present invention, the (E) polyhydric alcohol improves the solubility of the surfactant, and in particular, the dihydric polyhydric alcohol can improve the moisturizing sensation of the stratum corneum of the skin. Such (E) polyhydric alcohols are not particularly limited as long as they can be used in ordinary external skin preparations and can achieve the effects of the present invention. Examples include glycerin, 1,3-butylene glycol, propylene glycol, iso Pentyldiol, diglycerin, sorbitol, hexylene glycol, pentylene glycol, polyethylene glycol and the like can be mentioned. These (E) polyhydric alcohols may be used alone or in combination.
また、本発明において、前記(F)水は、皮膚への補水、保水による皮膚改善効果に欠かせないものである。かかる(F)水としては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、精製水等を使用することができる。 In the present invention, the water (F) is essential for rehydrating the skin and improving the skin by retaining water. The water (F) is not particularly limited as long as it can be used in ordinary external preparations for skin and the effects of the present invention can be obtained, but purified water and the like can be used.
さらに、本発明の半透明乃至透明の皮膚外用剤は、(G)ポリオキシエチレン水添ヒマシ油を有し、前記(G)ポリオキシエチレン水添ヒマシ油が、PEG-5水添ヒマシ油、PEG-10水添ヒマシ油、PEG-20水添ヒマシ油、PEG-30水添ヒマシ油、PEG-40水添ヒマシ油、PEG-50水添ヒマシ油、PEG-60水添ヒマシ油、PEG-80水添ヒマシ油およびPEG-100水添ヒマシ油からなる群から選ばれる1種または2種以上であることが、好ましい。(G)ポリオキシエチレン水添ヒマシ油としては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、例えば、日光ケミカルズ株式会社製のNIKKOL HCO-5(商品名)、NIKKOL HCO-10(商品名)、NIKKOL HCO-20(商品名)、NIKKOL HCO-30(商品名)、NIKKOL HCO-40(商品名)、NIKKOL HCO-50(商品名)、NIKKOL HCO-60(商品名)、NIKKOL HCO-80(商品名)、NIKKOL HCO-100(商品名)等を挙げることができる。 Further, the translucent or transparent external preparation for skin of the present invention has (G) polyoxyethylene hydrogenated castor oil, and the (G) polyoxyethylene hydrogenated castor oil is PEG-5 hydrogenated castor oil, PEG-10 hydrogenated castor oil, PEG-20 hydrogenated castor oil, PEG-30 hydrogenated castor oil, PEG-40 hydrogenated castor oil, PEG-50 hydrogenated castor oil, PEG-60 hydrogenated castor oil, PEG- It is preferably one or more selected from the group consisting of 80 hydrogenated castor oil and PEG-100 hydrogenated castor oil. The polyoxyethylene hydrogenated castor oil (G) is not particularly limited as long as it can be used in ordinary skin preparations for external use and the effects of the present invention can be obtained. For example, NIKKOL HCO-5 manufactured by Nikko Chemicals Co., Ltd. (trade name), NIKKOL HCO-10 (trade name), NIKKOL HCO-20 (trade name), NIKKOL HCO-30 (trade name), NIKKOL HCO-40 (trade name), NIKKOL HCO-50 (trade name), NIKKOL HCO-60 (trade name), NIKKOL HCO-80 (trade name), NIKKOL HCO-100 (trade name) and the like can be mentioned.
さらにまた、本発明の半透明乃至透明の皮膚外用剤は、pH調整剤を有することが好ましい。かかるpH調整剤としては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、例えば、クエン酸、リンゴ酸、酒石酸、乳酸、グリコール酸、グルタミン酸、アスパラギン酸、マロン酸、コハク酸、アジピン酸、2-アミノ-2-メチル-1-プロパノール等を挙げることができる。 Furthermore, the translucent or transparent external skin preparation of the present invention preferably contains a pH adjuster. Such pH adjusters are not particularly limited as long as they can be used in ordinary external preparations for skin and provide the effects of the present invention. Examples include citric acid, malic acid, tartaric acid, lactic acid, glycolic acid, glutamic acid, and asparagine. acid, malonic acid, succinic acid, adipic acid, 2-amino-2-methyl-1-propanol and the like.
また、本発明の半透明乃至透明の皮膚外用剤は、安定化剤を有することが好ましい。かかる安定化剤は、金属封鎖剤、酸化防止剤、防腐剤等により皮膚外用剤の安定性を向上するものである。前記安定化剤としては、通常の皮膚外用剤に使用でき、本発明の効果を得られるものであれば特に限定されないが、ヒドロキシエタンジホスホン酸、エデト酸及びその塩等の金属封鎖剤、ジブチルヒドロキシトルエン、ブチルヒドロキシアニソール、ソルビン酸、亜硫酸ナトリウム、エリソルビン酸、L-システイン塩酸塩等の酸化防止剤、メチルパラベン、エチルパラベン、安息香酸、安息香酸塩、サリチル酸、サリチル酸塩、フェノキシエタノール、水溶性カチオン抗菌剤、エチルヘキシルグリセリン、ビサボロール、ポリ-ε-リシン等の防腐剤等を挙げることができる。 In addition, the translucent or transparent external skin preparation of the present invention preferably contains a stabilizer. Such stabilizers improve the stability of external preparations for skin by means of sequestering agents, antioxidants, preservatives, and the like. The stabilizing agent is not particularly limited as long as it can be used in usual external preparations for skin and the effects of the present invention can be obtained. Antioxidants such as hydroxytoluene, butylated hydroxyanisole, sorbic acid, sodium sulfite, erythorbic acid, L-cysteine hydrochloride, methylparaben, ethylparaben, benzoic acid, benzoate, salicylic acid, salicylate, phenoxyethanol, water-soluble cationic antibacterial agents, antiseptics such as ethylhexylglycerin, bisabolol, poly-ε-lysine, and the like.
さらに、本発明の半透明乃至透明の皮膚外用剤は、本発明の効果を得ることができれば、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)および前記(G)ポリオキシエチレン水添ヒマシ油以外の界面活性剤をいっしょに配合することができる。この界面活性剤としては、例えば、プロピレングリコール脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリンと脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンソルビット脂肪酸エステル、ポリオキシエチレンラノリン・ラノリンアルコール・ミツロウ誘導体、ポリオキシエチレンステロール・水素添加ステロール、ポリエチレングリコール脂肪酸エステル、ポリオキシエチレンアルキルフェニルエーテル、ポリオキシエチレンアルキルアミン・脂肪酸アミド、ポリオキシエチレンアルキルフェニルホルムアルデヒド縮合物、ポリオキシエチレンアルキルエーテルリン酸・リン酸塩等を挙げることができる。 Furthermore, the semi-transparent to transparent external preparation for skin of the present invention can obtain the effects of the present invention, if the (C) polyoxyethylenated (1 to 40 E.O.) and polyoxypropylenated (1 to 40 E.O.) 30 P.O.) alkyl (C16-C24) and (G) a surfactant other than polyoxyethylene hydrogenated castor oil can be blended together. Examples of the surfactant include propylene glycol fatty acid ester, glycerin fatty acid ester, polyglycerin and fatty acid ester, polyoxyethylene glycerin fatty acid ester, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester, polyoxyethylene sorbit fatty acid ester, poly Oxyethylene lanolin/lanolin alcohol/beeswax derivative, polyoxyethylene sterol/hydrogenated sterol, polyethylene glycol fatty acid ester, polyoxyethylene alkylphenyl ether, polyoxyethylene alkylamine/fatty acid amide, polyoxyethylene alkylphenyl formaldehyde condensate, poly Oxyethylene alkyl ether phosphoric acid/phosphate and the like can be mentioned.
また、本発明の半透明乃至透明の皮膚外用剤は、前記(A)固形乃至半固形の油剤の含有量が1~5質量%であり、前記(B)常温で液状の炭化水素の油剤の含有量が0.5~8質量%であり、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)の含有量が1~8質量%であり、前記(D)炭素数が18~22の高級アルコールの含有量が0.5~2.0質量%であり、前記(E)多価アルコールの含有量が1~20質量%であり、前記(F)水で調整して100質量%に(含有)することが好ましい。かかる配合量とすることで、さっぱりとした使用感触で肌理改善効果を有する皮膚外用剤を得ることができ、特に、前記(A)固形乃至半固形の油剤による水分蒸散抑制効果を向上し、前記(B)常温で液状の炭化水素の油剤を水分蒸発抑制機能と前記(A)固形乃至半固形の油剤の溶剤として使用することができる。 Further, the translucent or transparent external preparation for skin of the present invention contains 1 to 5% by mass of the (A) solid or semi-solid oil, and (B) the hydrocarbon oil that is liquid at room temperature. The content is 0.5 to 8% by mass, and the (C) polyoxyethylenated (1 to 40 E.O.) and polyoxypropylenated (1 to 30 PO) alkyl (C16 to C24) is 1 to 8% by mass, the content of the (D) higher alcohol having 18 to 22 carbon atoms is 0.5 to 2.0% by mass, and the content of the (E) polyhydric alcohol The amount is 1 to 20% by mass, and it is preferable to (contain) 100% by mass by adjusting with (F) water. With such a blending amount, it is possible to obtain an external preparation for skin that has a refreshing feeling in use and an effect of improving the texture. (B) A hydrocarbon oil that is liquid at room temperature can be used as a solvent for the above-mentioned (A) solid or semi-solid oil as well as a water evaporation suppressing function.
さらに、前記(A)固形乃至半固形の油剤の含有量が1~3質量%であり、前記(B)常温で液状の炭化水素の油剤の含有量が1~5質量%であり、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)の含有量が1~3質量%であり、前記(D)炭素数が18~22の高級アルコールの含有量が0.5~1.0質量%であり、前記(E)多価アルコールの含有量が5~12質量%であり、前記(F)水で調整して100質量%に(含有)することがより好ましい。かかる配合量とすることで、さっぱりとした使用感触で肌理改善効果を有する皮膚外用剤を得ることができ、特に、前記(A)固形乃至半固形の油剤による肌理改善効果をより向上し、前記(B)常温で液状の炭化水素の油剤をエモリエント作用と前記(A)固形乃至半固形の油剤の溶剤として使用し、前記(D)炭素数が18~22の高級アルコールを前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)のパリセード層に溶解することでミセルを増大させることができ、さらに前記(E)多価アルコールのベタツキを少なくすることができる。 Further, the content of the (A) solid or semi-solid oil agent is 1 to 3% by mass, the content of the (B) hydrocarbon oil agent that is liquid at room temperature is 1 to 5% by mass, and the ( C) the content of polyoxyethylenated (1 to 40 E.O.) and polyoxypropylenated (1 to 30 PO) alkyl (C16 to C24) is 1 to 3% by mass; ) The content of a higher alcohol having 18 to 22 carbon atoms is 0.5 to 1.0% by mass, the content of the (E) polyhydric alcohol is 5 to 12% by mass, and the (F) water It is more preferable to adjust (contain) to 100% by mass. By setting such a blending amount, it is possible to obtain an external preparation for skin having a refreshing feeling in use and an effect of improving the texture. (B) A hydrocarbon oil that is liquid at room temperature is used as an emollient and as a solvent for (A) the solid or semi-solid oil, and (D) the higher alcohol having 18 to 22 carbon atoms is used as the (C) polyol. Micelles can be increased by dissolving in oxyethylenated (1-40 E.O.) and polyoxypropylenated (1-30 P.O.) alkyl (C16-C24) palisade layers, and (E) The stickiness of the polyhydric alcohol can be reduced.
また、本発明の半透明乃至透明の皮膚外用剤は、前記(G)ポリオキシエチレン水添ヒマシ油の含有量が1~5質量%であることが好ましく、2.5~3.5質量%であることがより好ましい。かかる配合量とすることで、本発明の半透明乃至透明の皮膚外用剤の安定性をより向上することができる。 In the translucent or transparent external preparation for skin of the present invention, the content of (G) polyoxyethylene hydrogenated castor oil is preferably 1 to 5% by mass, more preferably 2.5 to 3.5% by mass. is more preferable. With such a blending amount, the stability of the translucent or transparent skin preparation for external use of the present invention can be further improved.
本発明において、皮膚外用剤とは、人間の身体等に使用できるものであり、通常の化粧品の分類に属するものであり、医薬部外品、医薬品等の用途を排除するものではない。さらに、前記皮膚外用剤とは、基礎化粧品、メイクアップ化粧品、頭髪用化粧品等の用途を含むものである。 In the present invention, the external preparation for skin is one that can be used on the human body and the like, belongs to the classification of ordinary cosmetics, and does not exclude applications such as quasi-drugs and pharmaceuticals. Furthermore, the above-mentioned external preparation for skin includes uses such as basic cosmetics, make-up cosmetics, and hair cosmetics.
さらに、本発明において、本発明の効果が損なわれない範囲で、適宜他の成分等を添加することもできる。質的、量的範囲で上記以外の任意の成分を配合することができ、皮膚外用剤に通常配合される成分、例えば、保湿剤、香料、各種ビタミン剤、紫外線吸収剤、粉体や着色剤、薬効成分、無機塩類、植物抽出物など有用性成分等を配合することができる。 Furthermore, in the present invention, other ingredients can be added as appropriate within a range that does not impair the effects of the present invention. Any ingredient other than the above can be blended within a qualitative and quantitative range, and ingredients that are usually blended in external skin preparations, such as moisturizers, fragrances, various vitamins, ultraviolet absorbers, powders and colorants. , medicinal ingredients, inorganic salts, and useful ingredients such as plant extracts.
抽出液成分として、例えば、カミツレエキス、パセリエキス、スイカズラエキス、コメエキス、コメヌカエキス、ホップエキス、オウバクエキス、ヨクイニンエキス、センブリエキス、メリロートエキス、バーチエキス、カンゾウエキス、シャクヤクエキス、サボンソウエキス、ヘチマエキス、トウガラシエキス、レモンエキス、ゲンチアナエキス、シソエキス、アロエエキス、ローズマリーエキス、セージエキス、タイムエキス、ユーカリエキス、茶エキス、海藻エキス、キューカンバーエキス、チョウジエキス、ニンジンエキス、マロニエエキス、ハマメリスエキス、クワエキス、チンピエキス、ピーカンナッツエキス、グレープフルーツエキス、シークワーサーエキス、パッションフルーツエキス、ビワエキス、ブドウエキス、ローズフルーツエキス、クララエキス、ペパーミントエキス等の各種抽出成分が挙げられる。 Examples of extract components include chamomile extract, parsley extract, honeysuckle extract, rice extract, rice bran extract, hop extract, Phellodendron bark extract, coix seed extract, assembly extract, melilot extract, birch extract, licorice extract, peony extract, soapwort extract, loofah extract. , Capsicum extract, Lemon extract, Gentian extract, Perilla extract, Aloe extract, Rosemary extract, Sage extract, Thyme extract, Eucalyptus extract, Tea extract, Seaweed extract, Cucumber extract, Clove extract, Carrot extract, Horse chestnut extract, Hamamelis extract, Mulberry extract , chimp extract, pecan nut extract, grapefruit extract, shikuwasa extract, passion fruit extract, loquat extract, grape extract, rose fruit extract, clara extract, and peppermint extract.
保湿成分として、例えば、キシリトール、マルチトール、コンドロイチン硫酸ナトリウム、エラスチン、グルコサミン、ヒアルロン酸、シクロデキストリン、コラーゲン、胆汁酸塩等が挙げられる。 Examples of moisturizing ingredients include xylitol, maltitol, sodium chondroitin sulfate, elastin, glucosamine, hyaluronic acid, cyclodextrin, collagen, and bile salts.
薬効成分として、例えば、ビタミンA、ビタミンB、ビタミンC、ビタミンD、ビタミンEなどのビタミン類およびそれらの誘導体、グリチルリチン酸及びの誘導体、グリチルレチン酸及びの誘導体、尿素などの各種塩、クレアチニン、CoQ10、アスタキサンチン、ポリフェノール、セラミド等の成分が挙げられる。 Examples of medicinal ingredients include vitamins such as vitamin A, vitamin B, vitamin C, vitamin D, and vitamin E and their derivatives, glycyrrhizic acid and its derivatives, glycyrrhizic acid and its derivatives, various salts such as urea, creatinine, and CoQ10. , astaxanthin, polyphenols, and ceramide.
また、本発明において、半透明乃至透明の皮膚外用剤の製造方法としては、通常の皮膚外用剤の製造方法で製造することができ、油相成分と水相成分を加熱して製造する方法を用いることができる。 In the present invention, the translucent or transparent external preparation for skin can be produced by a conventional method for producing an external preparation for skin. can be used.
本発明において、半透明乃至透明の皮膚外用剤の製造方法の一例としては、前記(E)多価アルコールに前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)を溶解し、それに前記(A)固形乃至半固形の油剤と前記(B)常温で液状の炭化水素の油剤と前記(D)炭素数が18~22の高級アルコールとを溶解した油相を添加して混合する方法がある。 In the present invention, as an example of a method for producing a translucent or transparent external skin preparation, the (E) polyhydric alcohol is converted to the (C) polyoxyethylenated (1 to 40 E.O.) and polyoxypropylene (1-30 P.O.) Alkyl (C16-C24) is dissolved, and the above (A) solid or semi-solid oil, the above (B) the hydrocarbon oil that is liquid at room temperature, and the above (D) carbon number There is a method of adding and mixing an oil phase in which a higher alcohol of 18 to 22 is dissolved.
また、半透明乃至透明の皮膚外用剤の製造方法の他の一例としては、前記(F)水に前記(E)多価アルコールを溶解して水相とし、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)を溶解し、これに前記(A)固形乃至半固形の油剤と前記(B)常温で液状の炭化水素の油剤と前記(D)炭素数が18~22の高級アルコールを溶解して油相として、油相を水相に混合して可溶化する方法がある。 Further, as another example of the method for producing a translucent or transparent skin preparation for external use, the (E) polyhydric alcohol is dissolved in the (F) water to form an aqueous phase, and the (C) polyoxyethylenated ( 1 to 40 E.O.) and polyoxypropylenated (1 to 30 P.O.) alkyl (C16 to C24) are dissolved, and the (A) solid or semi-solid oil solution and the (B) room temperature There is a method of dissolving the liquid hydrocarbon oil and (D) a higher alcohol having 18 to 22 carbon atoms to form an oil phase, and mixing the oil phase with the water phase to solubilize it.
また、半透明乃至透明の皮膚外用剤の製造方法のさらに他の一例としては、前記(F)水に前記(E)多価アルコールを溶解して水相とし、前記(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)を溶解し、これに前記(A)固形乃至半固形の油剤と前記(B)常温で液状の炭化水素の油剤と前記(D)炭素数が18~22の高級アルコールを溶解して油相として、油相を水相に混合し、可溶化後に前記pH調整剤および/または前記安定化剤を混合する方法がある。 Further, as still another example of the method for producing a semi-transparent or transparent skin preparation for external use, the above-mentioned (E) polyhydric alcohol is dissolved in the above-mentioned (F) water to form an aqueous phase, and the above-mentioned (C) polyoxyethylenated (1-40 E.O.) and polyoxypropylenated (1-30 P.O.) alkyl (C16-C24) are dissolved, and the (A) solid or semi-solid oil and the (B) A hydrocarbon oil that is liquid at room temperature and the (D) higher alcohol having 18 to 22 carbon atoms are dissolved to form an oil phase. There is a method of mixing stabilizers.
以下、本発明について、実施例を用いてさらに詳細に説明するが、本発明はこれらの実施例に限定されるものではない。また、以下、処方中の数値は質量%を示す。 EXAMPLES The present invention will be described in more detail below using examples, but the present invention is not limited to these examples. Further, the numerical values in the formulations below indicate % by mass.
(実施例1~3、比較例1~5)
下記表1および表2に記載の処方で、下記製造方法に従って、実施例1~3、比較例1~5の皮膚外用剤を作製した。得られた皮膚外用剤について、下記評価方法で評価し、結果を下記表1および表2に併記した。
(Examples 1-3, Comparative Examples 1-5)
Using the formulations shown in Tables 1 and 2 below, external preparations for skin of Examples 1 to 3 and Comparative Examples 1 to 5 were prepared according to the production method below. The resulting external preparations for skin were evaluated by the following evaluation methods, and the results are shown in Tables 1 and 2 below.
(製造方法)
精製水に多価アルコール(ペンチレングリコールおよびBG)を溶解して水相とした。非イオン界面活性剤(PPG―4セテス-20およびPEG-10水添ヒマシ油)を溶解し、下記表1および表2中の固形及び半固形油と液状油と高級アルコールを溶解して油相とした。油相を水相に混合して可溶化後にフェノキシエタノールを混合溶解した。
(Production method)
A polyhydric alcohol (pentylene glycol and BG) was dissolved in purified water to form an aqueous phase. Nonionic surfactants (PPG-4 ceteth-20 and PEG-10 hydrogenated castor oil) are dissolved, solid and semi-solid oils, liquid oils and higher alcohols in Tables 1 and 2 below are dissolved to obtain an oil phase. and After the oil phase was mixed with the water phase and solubilized, phenoxyethanol was mixed and dissolved.
(評価方法)
(外観、安定性)
得られた皮膚外用剤の安定性は、作製当日と作製後1か月、3か月経過後に目視観察し、下記評価基準で評価した。
◎:半透明~透明
〇:半透明
△:白濁
×:白濁、分離
(Evaluation method)
(appearance, stability)
The stability of the resulting external preparation for skin was visually observed on the day of preparation and one month and three months after preparation, and evaluated according to the following evaluation criteria.
◎: Translucent to transparent 〇: Translucent △: Cloudy ×: Cloudy, separated
(使用性)
パネル(年齢27から75歳の官能試験従事者、男性1名、女性1名)により、使用性「べたつき」、「さっぱりさ」について官能試験を実施した。評価法は、評価用語の「べたつき」の肯定文に対して有る方向は(+)、無い方向は(-)とし、どちらでもない(±)を中心に+2と-2を加えた5段階で評価した。「さっぱりする」についても同様に、「さっぱりする」方向は(+)、「さっぱりしない」方向は(-)とした。
(Usability)
A sensory test was conducted on usability "stickiness" and "freshness" by a panel (sensory test participants aged 27 to 75, 1 male and 1 female). The evaluation method is a 5-point scale with (+) for the positive sentence of the evaluation term "stickiness", (-) for the absence, and +2 and -2 for neither (±). evaluated with Similarly, for "refreshing", the direction of "refreshing" was given by (+), and the direction of "not refreshing" was given by (-).
表1および表2の結果から、実施例1~3の皮膚外用剤は、安定性および使用性ともに良好であった。一方、比較例1~5の皮膚外用剤は、安定性が悪く、感触もべたつきがあるものであった。 From the results in Tables 1 and 2, the external preparations for skin of Examples 1 to 3 were good in both stability and usability. On the other hand, the external preparations for skin of Comparative Examples 1 to 5 were poor in stability and felt sticky to the touch.
(実施例4~7、比較例6)
下記表3に記載の処方で、上記製造方法に従って、実施例4~7、比較例6の皮膚外用剤を作製した。得られた皮膚外用剤について、上記評価方法で安定性について評価し、結果を下記表3に併記した。
(Examples 4 to 7, Comparative Example 6)
Using the formulations shown in Table 3 below, external preparations for skin of Examples 4 to 7 and Comparative Example 6 were prepared according to the production method described above. The obtained external preparation for skin was evaluated for stability by the evaluation method described above, and the results are also shown in Table 3 below.
表3の結果から、実施例4~7の皮膚外用剤は、安定性は良好であった。一方、比較例6の皮膚外用剤は、安定性が悪かった。
From the results in Table 3, the external preparations for skin of Examples 4 to 7 had good stability. On the other hand, the external preparation for skin of Comparative Example 6 had poor stability.
Claims (3)
(B)常温で液状の炭化水素の油剤と、
(C)ポリオキシエチレン化(1~40 E.O.)及びポリオキシプロピレン化(1~30 P.O.)アルキル(C16~C24)と、
(D)炭素数が18~22の高級アルコールと、
(E)多価アルコールと、
(F)水と、を有することを特徴とする半透明乃至透明の皮膚外用剤。 (A) a solid or semi-solid oil,
(B) a hydrocarbon oil that is liquid at room temperature;
(C) polyoxyethylenated (1-40 E.O.) and polyoxypropylenated (1-30 P.O.) alkyl (C16-C24);
(D) a higher alcohol having 18 to 22 carbon atoms;
(E) a polyhydric alcohol;
(F) A translucent or transparent skin preparation for external use, characterized by containing water.
前記(G)ポリオキシエチレン水添ヒマシ油が、PEG-5水添ヒマシ油、PEG-10水添ヒマシ油、PEG-20水添ヒマシ油、PEG-30水添ヒマシ油、PEG-40水添ヒマシ油、PEG-50水添ヒマシ油、PEG-60水添ヒマシ油、PEG-80水添ヒマシ油およびPEG-100水添ヒマシ油からなる群から選ばれる1種または2種以上である請求項1記載の半透明乃至透明の皮膚外用剤。 (G) having polyoxyethylene hydrogenated castor oil,
The (G) polyoxyethylene hydrogenated castor oil is PEG-5 hydrogenated castor oil, PEG-10 hydrogenated castor oil, PEG-20 hydrogenated castor oil, PEG-30 hydrogenated castor oil, PEG-40 hydrogenated One or more selected from the group consisting of castor oil, PEG-50 hydrogenated castor oil, PEG-60 hydrogenated castor oil, PEG-80 hydrogenated castor oil and PEG-100 hydrogenated castor oil. 2. The translucent or transparent skin preparation for external use according to 1.
The (C) polyoxyethylenated (1-40 E.O.) and polyoxypropylenated (1-30 PO) alkyl (C16-C24) are PPG-6 decyltetradeceth-30, PPG -6 decyltetradeceth-12, PPG-13 decyltetradeceth-24, PPG-6 decyltetradeceth-20, PPG-4 ceteth-1, PPG-8 ceteth-1, PPG-4 ceteth-10, 3. The translucent material according to claim 1 or 2, which is one or more selected from the group consisting of PPG-4 ceteth-20, PPG-5 ceteth-20, PPG-8 ceteth-20 and PPG-23 steareth-34. to transparent skin preparations for external use.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021109783A JP2023006915A (en) | 2021-07-01 | 2021-07-01 | Translucent or transparent topical skin preparation |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021109783A JP2023006915A (en) | 2021-07-01 | 2021-07-01 | Translucent or transparent topical skin preparation |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2023006915A true JP2023006915A (en) | 2023-01-18 |
Family
ID=85107804
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021109783A Pending JP2023006915A (en) | 2021-07-01 | 2021-07-01 | Translucent or transparent topical skin preparation |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP2023006915A (en) |
-
2021
- 2021-07-01 JP JP2021109783A patent/JP2023006915A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6010418B2 (en) | Emulsified composition | |
US20060204526A1 (en) | Emulsive composition containing Dapsone | |
JP5072245B2 (en) | Oil-in-water emulsified cloudy skin cosmetic | |
KR101154693B1 (en) | Cream-like o/w type emulsified composition and method for producing same | |
JP5766337B2 (en) | Cosmetics | |
JP2002193740A (en) | O/w-type emulsified composition | |
KR20160117111A (en) | Cosmetic composition containing a plant-derived emulsifying agent | |
KR102532929B1 (en) | Composition for skin cosmetics | |
JP2014019645A (en) | Cosmetic | |
JP5134197B2 (en) | Oil-in-water microemulsion and process for producing the same | |
JP2023006915A (en) | Translucent or transparent topical skin preparation | |
JP2006045061A (en) | Ceramides-containing composition, ceramides-containing aqueous preparation, and food and beverage, cosmetic and external preparation for skin, each containing the same composition or the same preparation | |
JP6081097B2 (en) | Oil-in-water emulsion composition | |
JP5706223B2 (en) | W / O / W emulsion composition | |
JP6355296B2 (en) | Skin preparation for external use | |
JP7165090B2 (en) | Stabilized high internal phase W/O type emulsion composition and cosmetics using the same | |
CA2535401C (en) | Emulsive composition containing dapsone | |
JP2023165421A (en) | Topical skin preparation | |
JP7265860B2 (en) | High internal phase W/O type emulsion composition and cosmetics using the same | |
JP2010059115A (en) | Skin care method | |
EP3582746B1 (en) | Cosmetic lotion | |
KR20230124615A (en) | aqueous emulsion | |
JP2000302668A (en) | 0/w creamy emulsified cosmetic | |
JP2023181387A (en) | External composition including azelaic acid, and method for producing the same | |
WO2023106121A1 (en) | Oil-in-water emulsion cosmetic |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20240402 |